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Abstract 
 
Resistance exercise and protein ingestion are synergistic in their capacity to stimulate muscle protein 
synthesis. Previous research has examined the effect of various factors related to protein ingestion 
(e.g. amount, type, co-ingestion with carbohydrates and proximity to resistance exercise) and their 
capacity to modulate muscle protein synthesis. However, there are many deficiencies in our current 
knowledge regarding the effect of several modifiable factors related to amino acid provision that may 
alter muscle protein synthesis. Therefore, the aim of this thesis was to determine 1) the anabolic effect 
of leucine on skeletal muscle cells, 2) the capacity for differences in the timing and distribution of 
protein ingestion to modulate skeletal muscle protein synthesis after a bout of resistance exercise, and 
3) the effect of resistance exercise and protein ingestion on the skeletal muscle anabolic response 
during dietary-induced energy deficit.  
 
The first study (chapter two) examined the anabolic response of muscle cells to increasing 
doses of leucine. Specifically, the effect of increasing doses of leucine on the mTOR-mediated 
signalling network, acute rates of protein synthesis, and chronic changes in cell size of C2C12 muscle 
cells was examined. Acute exposure to 1.51, 3.2, 5 and 16.1 mM leucine, increased phosphorylation 
of mTOR Ser2448 (~1.4 fold; P<0.04), 4E-BP1 Thr37/46 (~1.9 fold; P<0.001) and rpS6 Ser235/6 
(~2.3 fold; P<0.001), with no differences between leucine treatments. However, a dose-dependent 
response was observed for phosphorylation of p70S6k Thr389 where ≥5 mM leucine concentrations 
increased p70S6K phosphorylation compared to 1.51 mM (1.2 fold; P<0.02), and there was also a 
trend towards differences between 3.2 and 1.51 mM treatments. Chronic exposure (7 days) of 
differentiating myoblasts to 0.45, 1.51, 5 and 16.5 mM leucine resulted in increased cell diameter for 
concentrations ≥5 mM (~1.6 fold, P<0.001 vs control) but there was no effect of leucine on acute 
muscle protein synthesis. The current findings indicate that even low concentrations of leucine 
increase phosphorylation of the mTOR signalling pathway, and that only p70S6k Thr389 appears to 
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follow a leucine dose-dependent response. Despite the absence of leucine induced increases in acute 
protein synthesis, the results show that leucine up-regulates the mTOR signalling pathway and 
chronic exposure to ≥5 mM leucine enhances cell growth. 
The second study (chapter three) investigated how the in vivo skeletal muscle anabolic 
response is modulated by differences in the timing and distribution of protein intake throughout 
prolonged recovery (12 h) after a bout of resistance exercise. Twenty four healthy resistance trained 
males were assigned to three groups (n=8/group) and undertook a bout of resistance exercise (4 sets of 
10 repetitions at 80% of 1 RM) followed by ingestion of 80 g of whey protein throughout 12 h 
recovery as either: 8×10 g every 1.5 h (PULSE); 4×20 g every 3 h (intermediate: INT); or 2×40 g 
every 6 h (BOLUS). From muscle biopsies, obtained at rest and after 1, 4, 6, 7 and 12 h recovery, 
myofibrillar protein synthesis (MPS), mTOR signalling pathway phosphorylation and specific mRNA 
content were quantified. All ingestion protocols increased MPS above rest throughout 1-12 h recovery 
(88-148%, P<0.02), but INT elicited greater MPS than PULSE and BOLUS (31-48%, P<0.02). 
Differences in MPS between groups were evident during the 4-12 h recovery period. All treatments 
increased phosphorylation above resting values for mTOR Ser2448 (~2 to ~6 fold, P<0.05) and 
p70S6k Thr389 (~3 to ~26 fold; P<0.02) throughout recovery. The magnitude of phosphorylation of 
proteins of the mTOR signalling pathway generally followed a BOLUS>INT>PULSE hierarchical 
response. BOLUS suppressed the post-exercise increases in MuRF-1 mRNA and increased SLC38A2 
mRNA above all other time-points. In conclusion, 20 g of whey protein consumed every 3 h was 
superior to either PULSE or BOLUS feeding patterns for stimulating MPS throughout the day, and 
BOLUS was a more potent stimulus for modulating intracellular signalling and mRNA expression. 
The results of this study indicate that daily protein spread is an independent variable capable of 
modulating protein synthesis. 
The final study (chapter four) shows the effect of resistance exercise (REX) and protein 
intake on myofibrillar protein synthesis and markers of the anabolic status of skeletal muscle when 
energy availability (EA) is reduced. It has been previously shown that REX training and increasing 
the amount of dietary protein have potential to mitigate the loss of fat free mass (FFM) during energy 
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deficit (ED). However, the nature of the relationship between MPS, exercise, and protein during ED is 
not well characterized. The aim of this study was to determine the effect of 5 days ED (30 kcal∙kg-1 
Fat Free Mass (FFM)∙day EA) and energy balance (EB; 45 kcal∙kg-1 FFM∙ day EA) on basal MPS and 
cell signalling, after REX in the fasted state, and after REX and ingestion of whey protein (15 and 30 
g) during ED in young, healthy male (n=8) and female subjects (n=7). There were no sex-based 
differences for MPS. Basal rates of MPS were 27% lower in ED than EB (P<0.001). REX in the 
fasted state restored rates of MPS to those measured in resting EB while ingestion of 15 and 30 g of 
protein after REX in ED increased MPS ~16 and ~34% above resting EB (P<0.02). Basal 
phosphorylation of mTOR-mediated signalling was similar in ED and EB. p70 S6K thr389 
phosphorylation increased above EB with exercise and protein intake (~2-7 fold; P<0.05) but not with 
REX and placebo ingestion. In conclusion, short-term (5 day) ED down regulates basal MPS. 
However, a single bout of resistance exercise in ED returns MPS to resting EB values and ingestion of 
protein after REX further increases MPS above resting EB in a dose-dependent manner. The results of 
the present study show for the first time that following short-term ED, REX and post-exercise protein 
ingestion are capable of increasing MPS above resting EB. 
In summary, the studies undertaken for this thesis provide novel information for protein 
delivery to promote increases in muscle mass. Leucine concentration appears to be an important factor 
for modulation of intracellular translational signalling and cell growth in muscle cells. Manipulating 
the pattern of daily protein intake after a bout of REX is also an independent variable for regulating 
the muscle anabolic response. Specifically, medium sized protein meals (20 g) every 3 h were shown 
to be a superior protein delivery protocol to enhance MPS after REX. Finally, REX and protein intake 
are additive in their capacity to up-regulate MPS despite reduced EA. The results also indicate that the 
amount of protein required to maximally stimulate MPS may be increased during ED compared to 
EB.         
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1.1 Introduction  
The current global epidemic of lifestyle related chronic diseases in industrialised nations is closely 
associated with a rise in levels of physical inactivity and the decline in skeletal muscle metabolic 
capacity and loss of muscle mass (Parr et al. 2013; Wolfe 2006). The  age-related loss of muscle mass 
(i.e. sarcopenia) from the third decade of life further compromises the health status of sedentary adults 
with aging, primarily through decreased functional capacity and loss of independence of the elderly 
(Karagounis and Hawley 2010). Therefore, minimising the negative impact of a sedentary lifestyle 
and aging on maintenance of muscle function and mass is an important strategy for promoting health 
across the lifespan. In contrast, a key determinant of athletic performance is maximising the adaptive 
potential of skeletal muscle. Muscle mass determines, in part, the capacity for force generation but 
also contributes to other important aspects affecting performance including its influence on body 
composition (Haakonssen et al. 2013; Mettler et al. 2010; Morton et al. 2010; Phillips and Van Loon 
2011; Pikosky et al. 2008). The relationship between muscle mass and health and performance 
highlights the importance of understanding factors that determine protein balance and turnover in 
skeletal muscle, and the need to optimize exercise and nutrition to promote muscle quantity and 
quality.  
Resistance exercise and dietary protein are potent anabolic stimuli with the capacity to  
regulate muscle protein synthesis (Biolo et al. 1995a; Biolo et al. 1995b; Biolo et al. 1997; Burd et al. 
2011b; Cermak et al. 2012; Chesley et al. 1992; Moore et al. 2009b; Pennings et al. 2011b; Rennie et 
al. 1982). These stimuli act through both common and independent cellular pathways (Pasiakos 
2012), but their combination ultimately generates a transient (24-48 h) and additive anabolic response 
that results in a higher positive net muscle protein balance (Biolo et al. 1997; Burd et al. 2011b; 
Phillips 2004; Tipton et al. 1999). Many studies have examined the effect of different variables that 
can modulate muscle protein synthesis after  resistance exercise including the quantity  (Moore et al. 
2009a; Robinson et al. 2012; Yang et al. 2012a), timing (Beelen et al. 2008; Burke et al. 2012a; Fujita 
et al. 2009; Tipton et al. 2001) and type of protein ingestion (Borsheim et al. 2002; Burd et al. 2012c; 
Churchward-Venne et al. 2012; Tang et al. 2009; West et al. 2011), along with the effects of 
 6 
 
carbohydrate co-ingestion (Beelen et al. 2008; Borsheim et al. 2002; Koopman et al. 2007a; Miller et 
al. 2003). 
Enhancing skeletal muscle mass is vital for sustaining a healthy lifestyle and improving sports 
performance. Therefore, optimizing practices for modulating muscle mass is of paramount 
importance.  Despite the numerous studies examining protein ingestion and resistance exercise 
variables regulating muscle mass, important questions still remain. This chapter will review current 
literature related to key factors/mechanisms that modulate skeletal muscle protein synthesis. 
Principally, the effect of resistance exercise and amino acids on intracellular signalling machinery, the 
capacity for the pattern of daily protein ingestion to alter protein balance, and the effect of dietary 
energy deficit on muscle mass will be addressed. 
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1.2 Factors regulating skeletal muscle mass: role of amino acid availability and 
resistance exercise 
1.2.1 Cellular mechanisms 
 
Resistance exercise and aminoacidemia modulate a multiplicity of intracellular mechanisms 
regulating muscle mass. Many of these mechanisms have been the subject of extensive review 
elsewhere (Coffey and Hawley 2007; Flück and Hoppeler 2003; Hornberger and Esser 2004; 
Williams and Neufer 2010). This section will be limited to the review of some of the factors 
regulating translation initiation and elongation signal transduction, ubiquitin ligase (atrogene) and 
amino acid transporter mRNA expression and ultimately, muscle protein synthesis.  
1.2.1.1 Intracellular signalling  
 
Skeletal muscle cellular homeostasis can be disrupted by contraction of sufficient intensity and 
duration (the magnitude of these variables depend on the individuals’ characteristics as well as 
training status) and when repeated over time (i.e. weeks and months), ultimately leads to an 
adaptation response and shift in muscle phenotype (Coffey and Hawley 2007). The process of 
converting a mechanical stimulus into a biological response by mechanosensors within muscle cells is 
termed mechanotransduction (Wu et al. 2011). Similarly, aminoacidemia up-regulates the transport of 
amino acids into the muscle cell and the amino acid transporter itself has a dual role as a nutrient 
sensor and receptor (or “transceptor”) that transduces a nutrient sensitive signal that can activate the 
anabolic machinery (Hundal and Taylor 2009). A critical junction for the contraction and amino acid 
signalling response in muscle is the mechanistic target of rapamycin (mTOR) in the insulin/insulin-
like growth factor signalling pathway that regulates translation. 
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Figure 1.1  mTORC complexes redrawn from (Rivas et al. 2009a) and (Zoncu et al. 2011). 4E-BP1, 
eukaryotic translation initiation factor 4E binding protein 1. AICAR, 5-aminoimidazole-4-
carboxamide-b-D-ribofuranoside; DEPTOR, domain-containing mTOR-interacting protein; mLST8, 
mammalian lethal with SEC13 protein 8 (also known as GβL); mSIN1, mammalian stress-activated 
mitogen activated protein kinase-interacting protein 1 (also known as MAPKAP1); mTORC, 
mechanistic target of rapamycin complex; PRAS40, proline rich Akt Substrate of 40 kDa; PROTOR, 
protein observed with RICTOR; RAPTOR, Regulatory associated protein of mTOR; RICTOR, 
rapamycin-insensitive companion of mTOR; S6K1, ribosomal protein S6 kinase 1   
 
Regulation of translation initiation is a key step in muscle protein synthesis (Baar and Esser 
1999; Dennis et al. 2012) and mTOR complex 1 (mTORC1) integrates the signals triggered by both 
nutrients and exercise and modulates translation initiation (Figure 1.1) (Dibble and Manning 2013; 
Drummond et al. 2009). mTOR, an evolutionary conserved protein (Laplante and Sabatini 2012; 
Wullschleger et al. 2006), regulates translation initiation and elongation by coordinating the activity 
of eukaryotic translation initiation factor 4E binding protein 1 (4E-BP1) and p70S6 kinase (p70S6k) 
(Kimball and Jefferson 2010). 4E-BP1 is a binding protein acting on eukaryotic initiation factor 4E 
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(eIF4E) and prevents the formation of a pre-initiation complex (Figure 1.2) (Gingras et al. 1999; 
Kimball and Jefferson 2010). Phosphorylation of 4E-BP1 by mTORC1 derepresses the formation of 
the eIF4E-4E-BP1 complex and allows the eIF4E-eIF4G complex formation promoting translation 
initiation (Kimball et al. 1998; Pause et al. 1994). The p70S6k has numerous downstream effectors 
including ribosomal protein S6 (rpS6) (up-regulated) and eukaryotic elongation factor 2 kinase 
(eEF2K) (down-regulated) (Ruvinsky and Meyuhas 2006). rpS6 induces the up-regulation of specific 
mRNA with a 5’-oligopyrimidine tract, which encode for proteins of the translational apparatus 
(Meyuhas 2000) while eEF2K phosphorylates and down-regulates the eukaryotic elongation factor 2 
(eEF2) mediated translation elongation (Pigott et al. 2012). 
 
Figure 1.2 Simplified schematic of mTOR signalling for translation initiation and elongation. Arrows 
denote activation, bars denote inhibition. 4E-BP1, eukaryotic translation initiation factor 4E binding 
protein 1; AMPK, 5’ Adenosine Monophosphate Protein kinase; eEF2, eukaryotic elongation factor 2; 
eEF2K, eukaryotic elongation factor 2 Kinase; eIF4E, eukaryotic initiation factor 4E; IGF-1, Insulin 
like growth factor; mTOR, mechanistic target of rapamycin; p70S6k, p70S6 kinase;  PDK, 
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phosphatidylinositol dependent kinase; PI3K, phosphatidylinositol 3-kinase; PRAS40, proline rich 
Akt substrate 40; rpS6, ribosomal protein S6; TSC 1/2, tuberous sclerosis complex 1/2. 
Resistance exercise and intracellular signalling  
Resistance exercise without concomitant nutrient ingestion increases the phosphorylation of proteins 
of the mTOR signalling pathway (Figure 1.3) (Burd et al. 2010b; Dreyer et al. 2006; Koopman et al. 
2006b; Kumar et al. 2009b; Mascher et al. 2008; Mayhew et al. 2009; Tannerstedt et al. 2009; Terzis 
et al. 2010). In the majority of studies there is a consistent increase in the phosphorylation status of 
the main proteins involved in mTOR-mediated signalling that is typically observed within 4 h after an 
exercise bout. In particular, the p70S6K phosphorylation status is consistently increased above resting 
values after 1-2 h post exercise recovery. The phosphorylation of p70S6k appears to be the best 
available surrogate marker of skeletal muscle anabolism outside of direct measures of fractional 
synthetic rate, and has been shown to have a modest correlation with acute increases in muscle protein 
synthesis (Burd et al. 2010a; Fry et al. 2011; Kumar et al. 2009b) and chronic changes in whole body  
FFM and type IIA fibre cross sectional area (CSA) after 16 weeks of resistance training (Terzis et al. 
2010). The 4E-BP1 phosphorylation status following resistance training has not been subject to the 
same level of scientific scrutiny but has been shown to correlate with myofibrillar FSR 24 h after a 
bout of resistance exercise (Burd et al. 2010b). 
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Figure 1.3 Simplified schematic of the resistance exercise and amino acid sensing converging at 
mTORC1. Arrows denote activation, bars denote inhibition. Dashed lines with arrows point towards 
physiological processes. 4E-BP1, eukaryotic translation initiation factor 4E binding protein 1; eEF2, 
eukaryotic elongation factor 2; eEF2K, eukaryotic elongation factor 2 Kinase; eIF4E, eukaryotic 
initiation factor 4E; FAC, Focal Adhesion Complex; FAK, Focal Adhesion Kinase; IGF-1, Insulin 
like growth factor; mTORC1, mechanistic target of rapamycin complex 1; p70S6k, p70S6 kinase; PA, 
Phosphatidic Acid; PDK, phosphatidylinositol dependent kinase; PLD, Phospholipase D; PI3K, 
phosphatidylinositol 3-kinase; PRAS40, proline rich Akt substrate 40; Rags, Rag GTPases; RHEB, 
Ras homolog enriched in brain; rpS6, ribosomal protein S6; TSC 1/2, tuberous sclerosis complex 1/2; 
Vps34, Vacuolar protein sorting 34.  
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Amino acids and exercise intracellular signalling 
An increase in amino acid availability up-regulates muscle protein synthesis (Rennie et al. 1982) and 
the processes underlying this effect appear to be mediated by intracellular increases in amino acids 
(Dibble and Manning 2013). Of all of the amino acids, leucine generates the greatest magnitude of 
translation initiation signalling (Atherton et al. 2010b; Deldicque et al. 2008). The anabolic effect of 
leucine on skeletal muscle cells has been reported in both cell and tissue culture (Atherton et al. 
2010b; Buse and Reid 1975; Deldicque et al. 2008; Fulks et al. 1975) and also in animal (Anthony et 
al. 2000a; Anthony et al. 2000b; Boutry et al. 2013; Escobar et al. 2007; Escobar et al. 2006) and 
human  models (Churchward-Venne et al. 2012; Koopman et al. 2006a; Wall et al. 2013).  
The results of several studies show that translation initiation induced by amino acids is down-
regulated by rapamycin (an mTOR inhibitor) indicating the amino acid-mediated effect on anabolic 
signalling occurs in a mTOR-dependent manner (Figure 1.3) (Haegens et al. 2012; Hara et al. 1998; 
Vary et al. 2007). Current knowledge of the amino acids sensors and precise mechanisms regulating 
translation signalling and muscle protein synthesis remains incomplete. The lysosome has been 
identified as an important sub-cellular location for the response to increases in amino acid 
concentration. The anabolic signal at the lysosome is mediated, at least in part, by vacuolar ATPase 
proteins which activate “Ragulator”, a protein attached to the lysosomal membrane (Bar-Peled et al. 
2012). Ragulator is a guanidine exchange factor (GEF) that switches Rag GTPases to their active 
form (Bar-Peled et al. 2012; Sancak et al. 2010) facilitating the phosphorylation and activation of 
mTOR by the kinase Ras homologue enriched in brain (Rheb) (Kim et al. 2008; Sancak et al. 2008). 
Other proteins purported to sense AA availability and enhance mTOR signalling are Vps34 (Backer 
2008; Nobukuni et al. 2005) and inositol monophosphate multikinase (Kim et al. 2011). Rag GTPases 
seem to have a central role in amino acid sensing mechanisms, given that knock-out of Rag GTPases 
ablates the stimulatory effect of leucine on the mTORC1 signalling pathway (Sancak et al. 2008). 
In summary, intracellular signalling pathways up-regulated by exercise and amino acids 
converge at mTORC1 and when these stimuli are combined, generate a synergistic effect on the 
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phosphorylation status of proteins proximal to translation initiation compared to protein ingestion 
(Burd et al. 2011b; Karlsson et al. 2004) or resistance exercise alone (Burke et al. 2012a; Koopman et 
al. 2006b; Reitelseder et al. 2011). 
1.2.1.3 Gene Expression 
 
The central dogma of molecular biology dictates that synthesis of cellular protein via gene expression  
includes transcription of sections of genetic code from DNA to messenger (m)RNA which is 
subsequently translated into a new functional protein (Crick 1970; Crick 1958). Generally, the 
transient increase in rates of gene transcription and subsequent increase in mRNA content leads to an 
increased protein content of that specific protein (Day and Tuite 1998; Flück and Hoppeler 2003), an 
effect that has been observed for specific genes contributing to endurance exercise adaptation (Perry 
et al. 2010). Given that it may be a rate limiting step in protein synthesis, this section of the review 
will discuss transcriptional activity of mRNA for select proteins associated with protein degradation 
and amino acid transport and metabolism in skeletal muscle.  
Ubiquitin ligases 
Cellular proteins undergo continual synthesis and degradation which is essential to maintain cellular 
homeostasis (Mitch and Goldberg 1996). Changes in the rates of protein synthesis and degradation is 
also an integral factor in the adaptation response in skeletal muscle (Phillips et al. 1997). There are 
different proteolytic systems in the muscle cell, and these include but are not limited to lysosomal, 
mitochondrial protease and Ubiquitin-proteasome regulated pathways (Clague and Urbé 2010; Mitch 
and Goldberg 1996). The proteasome is a primary system through which proteins are hydrolysed and 
degraded (Finley 2009; Jensen et al. 1995; Ward et al. 1995). Proteins are tagged for degradation by 
the proteasome via addition of the small protein ubiquitin, a process that is mediated by enzymes 
called ubiquitin ligases (E3) (Coux et al. 1996) (Figure 1.4). The genes ‘muscle really interesting 
novel gene finger 1’(MuRF-1) and ‘Atrogin-1’ (also known as MAFBX) code for two specific E3 
ubiquitin ligases in skeletal muscle that are up-regulated in a variety of atrophy and disuse models 
(Bodine et al. 2001). Though MuRF-1 and Atrogin were originally only associated with muscle 
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atrophy, they are now also thought to play an important role in muscle myofibril remodelling in 
response to resistance exercise (Foletta et al. 2011; McElhinny et al. 2002; Reid 2005).    
 
 
Figure 1.4 Simplified schematic of protein degradation by the ubiquitin proteasome pathway. Blunted 
arrow indicates up or down-regulation of specific E3 ligases depending on whether the resistance 
exercise and dietary amino acids are provided alone or in combination. Adapted from (Lecker et al. 
1999). E1, ATP dependent ubiquitin activating enzyme; E2, Ubiquitin carrier proteins; E3, ubiquitin 
ligases. 
Resistance exercise has been shown to transiently increase MuRF-1 mRNA between 1-4 h 
post exercise recovery (Borgenvik et al. 2012; Drummond et al. 2008; Glynn et al. 2010; Louis et al. 
2007; Mascher et al. 2008; Reitelseder et al. 2013; Yang et al. 2006), an effect which seems to be 
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independent of muscle fibre type (Yang et al. 2006). Thereafter, MuRF-1 mRNA content returns to 
pre-exercise values (Louis et al. 2007; Manini et al. 2011; Yang et al. 2006) (Figure 1.5). Conversely, 
Atrogin-1 seems to remain unchanged during the early post-exercise recovery (1-3 h) period 
(Borgenvik et al. 2012; Coffey et al. 2006; Drummond et al. 2008; Glynn et al. 2010; Manini et al. 
2011; Mascher et al. 2008; Reitelseder et al. 2013; Yang et al. 2006), and has been reported to be 
down-regulated 8-50 h after a bout of resistance exercise (Louis et al. 2007; Mascher et al. 2008; 
Reitelseder et al. 2013). The effect of nutrients on ubiquitin ligase mRNA expression seems to follow 
a similar pattern to that induced by an exercise stimulus. Studies incorporating a hyperinsulinemic or 
hyperaminoacidemic clamp have reported that MuRF-1 mRNA remains unchanged at insulin levels 
equivalent to ‘fed state’ (Adegoke et al. 2009; Greenhaff et al. 2008) but MuRF-1 expression 
increases at ‘physiologically high’ insulin levels (Greenhaff et al. 2008). Alternately, Atrogin-1 
mRNA appears to remain unchanged (Adegoke et al. 2009) or is down-regulated (Greenhaff et al. 
2008) with elevated circulating insulin concentrations.  
The ingestion of nutrients after a bout of resistance exercise generates divergent atrogene 
responses when compared to those of nutrients or resistance exercise in isolation. For example, 
ingestion of milk derived protein and BCAAs at rest has been shown to have no effect on MuRF-1 
mRNA content (Borgenvik et al. 2012; Reitelseder et al. 2013) but high intensity resistance exercise 
induced increases in MuRF-1 mRNA are attenuated by BCAA ingestion (Borgenvik et al. 2012). 
Atrogin 1 mRNA content has been shown to remain unchanged by the intake of milk derived proteins 
(Reitelseder et al. 2013) but data also show a decrease in mRNA by the intake of BCAAs at rest and 
following resistance exercise (Borgenvik et al. 2012). The divergent responses could be attributed to 
the different quantities of BCAA consumed by subjects in each study (65 mg∙kg-1 vs. 85 mg∙kg-1 body 
mass) but the paucity of data prevents definitive conclusions regarding the effect of amino acid 
ingestion on ubiquitin ligase expression (Borgenvik et al. 2012; Reitelseder et al. 2013). 
Figure 1.5 Atrogin-1 and MuRF-1 mRNA changes during recovery after a bout of resistance exercise. 
Refer to (Louis et al. 2007) “Fig. 1 RE”. 
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Amino acid transport and metabolism 
Leucine is a key amino acid for regulating protein synthesis and amino acids are the necessary 
building blocks for new proteins. The amino acid transporters have been the subject of scientific 
scrutiny because of their capacity to modulate the anabolic response of cells (Bevington et al. 2002; 
Christie et al. 2002; Dall'Asta et al. 1990; Evans et al. 2007; Hundal and Taylor 2009; Hyde et al. 
2003; Verrey 2003). Specifically, System A and System L amino acid transporters have received 
special attention as they seem to work together to regulate the molecular processes whereby amino 
acids  enter  the cell (Nicklin et al. 2009) (Figure 1.6).  
 
Figure 1.6 Model of essential amino acid transport inside a eukaryotic cell, adapted from (Nicklin et 
al. 2009). Glutamine enters the cell through System A amino acid transporter. Subsequently, 
intracellular glutamine is exchanged through antiport with essential amino acids by System L. 
 
The extent to which the membrane content (i.e. number) of amino acid transporters can 
influence the anabolic response of human skeletal muscle is not well understood. Drummond and 
colleagues showed that a bolus feeding of 10 g of essential amino acids increased the mRNA 
expression of both SNAT 2 (system A transporter) and LAT 1 (system L transporter) with a 
concomitant increase in their protein content two and three h following protein ingestion, respectively 
(Drummond et al. 2010). Moreover, resistance exercise in isolation has also been shown to elevate 
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system L (3 and 6 h post exercise) and system A (6 and 24 h post exercise) mRNA content and result 
in an increase in total protein content at 6 and 24 h, respectively (Drummond et al. 2011). 
Additionally, the effect of resistance exercise prior to protein intake has been shown to up-regulate 
both system L and A mRNA compared to protein intake alone (Churchward-Venne et al. 2012). 
Drummond and colleagues have also provided some early evidence for changes in System L and  
System A mRNA and protein content in muscle after 7 days of bed-rest (Drummond et al. 2012). 
Specifically, the amino acid transporter mRNA response to protein was impaired and muscle 
signalling pathways and protein synthesis were also less responsive. However, there was no alteration 
of the capacity of the muscle to incorporate phenylalanine and the extent to which amino acids 
transporters can modulate the anabolic response is unclear (Drummond et al. 2012). 
Branched-chain amino acid aminotransferase (BCAT) is a component of a multi-enzyme 
complex that catalyses the first step of deamination of branched chain amino acids (BCAA) (Islam et 
al. 2007) and has been shown to be down regulated in skeletal muscle during chronic periods of 
hypertrophy (Chaillou et al. 2013). At present, it appears that an increase in BCAT gene expression, 
and consequently in protein content, results in a reduced anabolic stimulus in response to exogenous 
amino acids due to greater BCAA degradation (Chaillou et al. 2013; Shimizu et al. 2011). Elevated 
leucine oxidation  is considered a marker of excess protein intake (Motil et al. 1981) and excessive 
protein ingestion may represent a variable that has the capacity to up-regulate the content of the 
BCAT enzyme. Despite increasing levels of protein intake stimulating acute leucine oxidation  
(Moore et al. 2009a) there are no studies in humans or animals to date that have determined the effect 
of resistance exercise or varying doses of protein intake on BCAT expression and subsequent changes 
in BCAA oxidation. 
1.2.2 Protein synthesis in human skeletal muscle 
 
In 1982 Rennie and colleagues (Rennie et al. 1982) pioneered research in the area of amino acid-
induced modulation of muscle protein synthesis. These workers demonstrated that increased amino 
acid availability was able to double the early (5 h) rates of muscle protein synthesis compared to rest. 
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Since that time further research has characterised mechanisms associated with changes in muscle 
protein synthesis and breakdown through alterations in amino acid availability and dietary protein 
intake. This section reviews some of the fundamental concepts inherent to the regulation of muscle 
protein synthesis by exercise and feeding.  
1.2.2.1 Measurement of muscle protein synthesis and net protein balance  
 
Protein balance in skeletal muscle is a consequence of the dynamic interaction between rates of 
protein breakdown and protein synthesis (Mitch and Goldberg 1996).  Net muscle protein balance is 
determined by the difference between  protein synthesis and protein breakdown and is equal to zero 
when there is no net muscle protein gain or loss (Phillips et al. 1997). Net balance follows a diurnal 
wave-like pattern of fluctuation between positive and negative values with amino acid intake and 
exercise being key stimuli for  the magnitude of the physiological responses (Figure 1.7) (Phillips 
2004). It has been suggested that the main locus of control for muscle mass is muscle protein 
synthesis (Phillips 2009; Phillips et al. 1997).  
The precursor-product method is a common approach to quantify muscle protein synthesis 
and detailed methods have been outlined elsewhere (Wolfe and Chinkes 2005). This method uses the 
administration of a primed continuous infusion of labelled amino acid, and a prerequisite for a valid 
calculation of muscle protein fractional synthetic rate (FSR) is reaching an isotopic steady-state 
enrichment throughout the experimental period (Rennie et al. 1994; Wolfe and Chinkes 2005). Tracer 
enrichment in muscle protein from biopsies can be accurately measured and rates of protein synthesis 
determined as the average of incorporation of tracer through the following equation: 
Where:  
Et0, is the enrichment in the protein-bound tracer at first time-point (blood or muscle biopsy)  
Et1, is the enrichment of the protein-bound tracer at a subsequent muscle biopsy 
FSR (%/h) = { (Et1 – Et0) / [Ep (t1 – t0)] } x  100  
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(t1 – t0), is the incorporation time 
Ep, is the mean enrichment available for the pool 
 
Figure 1.7 Fluctuation of muscle protein balance during the day after meals (orange line) and after 
meals with a bout of resistance exercise incorporated (green line). A and B areas under the curves 
represent the magnitude of periods of positive and negative net balance respectively. C and D, 
represent the difference in positive and negative balance between the effects of meal only vs meal 
plus resistance exercise. Refer to (Phillips 2004) Fig 3. 
 
Studies that have simultaneously determined rates of protein synthesis and breakdown show 
that changes in protein synthesis are most indicative of the net anabolic state of skeletal muscle in 
both the fasted and fed states  (Beelen et al. 2008; Biolo et al. 1997; Glynn et al. 2010; Koopman et al. 
2005; Phillips et al. 1997; Phillips et al. 1999). More recently, advances in laboratory techniques have 
made it possible to determine muscle protein synthesis in specific muscle protein sub-fractions (i.e. 
myofibrillar, sarcoplasmic, mitochondrial and collagen). Given the relative difference in the total 
protein content between muscle fractions (Figure 1.8) it is not surprising the response and contribution 
to global muscle protein synthesis is different (Moore et al. 2009b). Thus, assessing the fractional 
synthetic rates of specific protein sub-fractions is important to help determine the specificity of the 
anabolic response.  
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Figure 1.8 Relative contribution to total protein of specific muscle protein sub-fractions. (Haus et al. 
2007; Neti et al. 2009; Rooyackers et al. 1997) 
 
1.2.2.2 Protein quality and quantity 
 
Increasing amino acid availability through oral ingestion of protein has comparable effects on muscle 
protein synthesis as increasing aminoacidemia through intravenous infusion (Tipton et al. 1999). 
Additionally, the acute ingestion of a single bolus of protein appears to induce an increase in rates of 
muscle protein synthesis in a dose-dependent manner (Figure 1.9) (Cuthbertson et al. 2005; Moore et 
al. 2009a; Pennings et al. 2012). Specifically, Cuthbertson and colleagues (2005) and Moore and co-
workers (2009a) have shown that muscle protein synthesis increases with increasing amino acid 
concentration and plateaus when ingesting ~20 g or more of high biological value protein (or ~10 g 
EAA) at rest or after a bout of resistance exercise (Cuthbertson et al. 2005; Moore et al. 2009a).  The 
net result of larger boluses (>20 g) of protein ingestion is an increase in the oxidation of amino acids 
(Moore et al. 2009a). Taken together, this indicates that acute protein ingestion above ~20 g merely 
increases protein oxidation without any beneficial effect on skeletal muscle protein balance. However, 
Pennings and colleagues (2012) have also shown that higher doses of amino acids may have potential 
to elevate muscle protein synthesis in the elderly, an effect that is in contrast to previously published 
data in an aged population (Cuthbertson et al. 2005).  
Sarcoplasmic (30-35%)
Mitochondrial (5-10%)
Collagen (~15%)
Myofibrillar (50-60%)
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Figure 1.9 Ingested protein dose response and rates of mixed muscle protein synthesis. Refer to 
(Moore et al. 2009a) “Fig 2”. 
The quality of ingested protein is another factor affecting the anabolic response in skeletal 
muscle. Amino acid composition and the rate of digestion/absorption are qualitative factors that can 
influence muscle protein synthesis (Koopman et al. 2009; Pennings et al. 2013; Tang et al. 2009). The 
rate of digestibility and absorption is dependent on the source (Burke et al. 2012b; Conley et al. 2011) 
and structure of protein (Koopman et al. 2009; Pennings et al. 2013), whereas amino acid composition 
of the protein depends on the dietary source from which it is derived (Burke et al. 2012b; Tang et al. 
2009). A key factor of ingested protein for modulating rates of muscle protein synthesis is the leucine 
content (Churchward-Venne et al. 2012; Drummond et al. 2009; van Loon 2012), and it has been 
hypothesised that a “leucine trigger” may exist whereby the rate of muscle protein synthesis is 
determined by the relative leucinemia in the muscle cell, such that attainment of a specific 
concentration representing a “leucine threshold” results in maximal rates of protein synthesis (Hawley 
et al. 2011; Rennie 2007). However, at present it is unclear what concentration/s define the theoretical 
“leucine threshold” in vivo skeletal muscle across a range of physiological conditions. 
The maximal stimulation of muscle protein synthesis by increased amino acid availability at 
rest occurs after a short latency period and is transient such that the duration of the effect is limited 
(Atherton et al. 2010a; Bohe et al. 2001) (Figure 1.10). An increase in blood aminoacidemia is 
followed by an increase in muscle protein synthesis after approximately 30 min and despite 
continuous amino acid availability, rates muscle protein synthesis returns to resting values after ~120 
min (i.e. ~90 min elevated protein synthesis) (Atherton et al. 2010a; Bohe et al. 2001). The limited 
duration of elevated muscle protein synthesis was first reported via continuous intravenous amino acid 
infusion (Bohe et al. 2001) and recently reported following oral ingestion of a large bolus (48 g) of 
fast digested whey protein (Atherton et al. 2010a). This phenomenon has been termed the ‘muscle full 
effect’ in reference to Millward’s theory of  limitations in the anabolic/growth response of skeletal 
muscle (Millward et al. 1994). Accordingly, these data indicate that the continuous over-supply of 
amino acids is an intervention that fails to sustain increases in muscle protein synthesis for prolonged 
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periods and that a latency or ‘reset’ period is required for the protein synthesis machinery before 
being able to be stimulated again.    
Figure 1.10. Data characterising the muscle full effect. 48 g whey protein ingested at time 0 min. For 
FSR, data reported is for the resting, 0-45, 46-90, 91-180,181-270 and 271-360 min periods. Refer to 
(Atherton et al. 2010a) “Fig.  5 C” 
 
1.2.2.3 Resistance exercise and protein ingestion   
 
The concomitant effects of resistance exercise and protein ingestion (Cuthbertson et al. 2005; Moore 
et al. 2009a) augments the amplitude (Biolo et al. 1997; Burd et al. 2011b; Pennings et al. 2011b; 
Yang et al. 2012a; Yang et al. 2012b) and duration (Moore et al. 2009b) of muscle protein synthesis, 
generating maximal rates of synthesis in the myofibrillar protein fraction (Burd et al. 2011b) (Figure 
1.11).   
 
 
Figure 1.11 Increased amplitude (A) and duration (B) of muscle protein synthesis induced by protein 
ingestion following a bout of resistance exercise. (A) Refer to (Biolo et al. 1997) “Fig 3”; (B) Refer to 
(Moore et al. 2009b) “Fig 3” 
 
Amino acid infusion during the early (3 h) recovery period after a bout of resistance exercise 
can increase rates of mixed muscle protein synthesis 1.5 fold compared to amino acid infusion alone 
(Biolo et al. 1997) (Figure 1.11 A). Oral ingestion of protein can be equally effective as amino acid 
infusion for enhancing muscle protein synthesis following exercise, despite the potential of amino 
acid absorption in the early recovery to be impaired by significant exercise induced limb hyperaemia 
(Pennings et al. 2011b; Tipton et al. 1999; van Wijck et al. 2013). Furthermore, a study using 
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intrinsically labelled milk protein ingested after a bout of resistance exercise has shown no differences 
in blood amino acid availability between protein ingestion at rest or after a bout of resistance exercise 
(Pennings et al. 2011b). Importantly, the enhanced response to protein intake in skeletal muscle is not 
limited to the early post exercise recovery period, and muscle protein synthesis with exercise and oral 
protein ingestion has been shown to remain elevated for at least 24 h (Burd et al. 2011b). 
1.2.3 Aminoacidemia and regulation of protein synthesis 
 
The protein digestibility corrected amino acid score (PDCAAS) is an index that was established to 
provide information on the biological value or quality of a protein source i.e. the total amino acid 
availability after digestion (Schaafsma 2012). However, the PDCAAS profile fails to account for the 
rate of digestion and absorption and the subsequent appearance of amino acids in circulation. 
Consequently, the effect of different aminoacidemia kinetics through the use of proteins of varying 
quality and digestibility  has been an area of intense scientific scrutiny (Boirie et al. 1997; Burd et al. 
2012c; Churchward-Venne et al. 2012; Dangin et al. 2003; Hartman et al. 2007; Katsanos et al. 2008; 
Pennings et al. 2011b; Reitelseder et al. 2011; Tang et al. 2009; Wall et al. 2013; West et al. 2011). 
Based on the aminoacidemia profile generated by the ingestion of different types of proteins, 
an additional classification system of  ‘fast’ or ‘slow’ proteins has been proposed (Boirie et al. 1997; 
Frühbeck 1998). Casein and whey protein are two constituents of milk protein widely used in the 
majority of studies and are examples of slow and fast proteins, respectively. Whey protein ingestion 
generates a rapid, high peak aminoacidemia with a rapid return to baseline values, whereas casein 
induces a lower, sustained aminoacidemia before returning to baseline values. Of note, the rate of 
digestion of casein can be altered by hydrolyzation to elicit an aminoacidemia comparable to whey, 
indicating that the inherent structure of casein protein determines its digestion and absorption 
(Koopman et al. 2009; Pennings et al. 2011b).  Accordingly, the protein source is an important 
variable for determining the aminoacidemia kinetics and the classification of ‘slow’ and ‘fast’ is 
relative to the aminoacidemia profile elicited by different protein sources (Figure 1.12) (Burke et al. 
2012b; Conley et al. 2011; Pennings et al. 2013).  
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Figure 1.12 Aminoacidemia kinetics after ingestion of equal amounts of fast and slow proteins 
(hydrolysed casein and casein respectively). Refer to (Koopman et al. 2009) “Fig 2” 
 
Ingestion of a single bolus of micellar casein at rest generates a higher whole body net protein 
balance compared to fast protein ingestion (Boirie et al. 1997; Dangin et al. 2001; Dangin et al. 2003; 
Fouillet et al. 2002; Lacroix et al. 2006). This is likely due to the potential for higher levels of protein 
oxidation with ingestion of a rapidly digested, fast protein while lower sustained aminoacidemia with 
slow proteins ultimately elicits a higher net balance  (Boirie et al. 1997; Dangin et al. 2001; Dangin et 
al. 2003).  
To date, few studies have directly compared the difference between whey and casein 
ingestion at rest on muscle protein synthesis in young subjects (Tang et al. 2009). Tang and 
colleagues have reported a superior effect of whey compared to casein on resting muscle protein 
synthesis. However, the measurement of muscle protein synthesis was limited to 3 h after protein 
ingestion, a ‘window’ where the whole body protein synthetic response has also been reported to be 
superior with fast compared to slow protein ingestion (Dangin et al. 2001; Dangin et al. 2003). Moore 
and co-workers and Churchward-Venne and colleagues have used equivalent quantities of whey 
protein and shown an increase in muscle protein synthesis 1-3 h at rest that returned to basal values  3-
5 h after ingestion (Churchward-Venne et al. 2012; Moore et al. 2009b). Taken together, despite a 
paucity of data it appears there is no obvious benefit of ingesting fast compared to slow proteins on 
muscle protein synthesis at rest in a young population. 
The effect of ingesting slow and fast protein on muscle protein synthesis in elderly 
populations at rest and after exercise (Burd et al. 2012c; Dideriksen et al. 2011; Katsanos et al. 2008; 
Koopman et al. 2009; Pennings et al. 2011a) and in young subjects after resistance exercise 
(Reitelseder et al. 2013; Reitelseder et al. 2011; Tang et al. 2009; West et al. 2011; Wilkinson et al. 
2007) has been investigated in several studies. The ingestion of fast proteins seems to be beneficial 
independent of age when consumed after resistance exercise (Burd et al. 2012c; Tang et al. 2009; 
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West et al. 2011). Reitelseder and co-workers have shown no difference in the muscle protein 
synthetic response elicited by the ingestion of whey compared with casein after resistance exercise in 
young subjects (Reitelseder et al. 2011). However, an important consideration when interpreting their 
data is that the study design utilised a caseinate rather than standard micellar casein beverage.  
One approach to examine the effects of differences in blood aminoacidemia kinetics 
independent of the protein source is to manipulate the quantity and timing of ingestion of the same 
“fast” protein (West et al. 2011). West and colleagues determined the effect of 25 g of whey protein 
ingested either in a single bolus or as ten 2.5 g “pulses” to mimic the aminoacidemia generated by the 
ingestion of a slow protein. Such an approach aims to control for confounding factors associated with 
use of different sources of protein like amino acids content, particularly leucine. The results show that 
a rapid hyperaminoacidemia after resistance exercise was associated with a higher rate of myofibrillar 
protein synthesis compared to slow, more sustained hyperaminoacidemia throughout a 5 h recovery 
period (West et al. 2011).   
There are a number of permutations for the regulation of whole body and muscle-specific 
protein synthesis when ingesting different protein sources with varying digestion and absorption 
kinetics. Current scientific evidence is limited, and additional studies are needed to better understand 
the role of aminoacidemia on protein balance in humans. Nonetheless, it appears that protein intake 
utilising a large bolus of rapidly digested protein may be beneficial for augmenting muscle protein 
synthesis that occurs after resistance exercise, an effect that has yet to be observed at rest. 
1.3 Timing of protein intake 
1.3.1 Timing of protein intake and whole body protein balance   
 
The capacity for the timing of amino acid ingestion to modulate whole body protein synthesis has 
been identified as an important factor regulating protein balance since the 1940s (Geiger 1950). 
Surprisingly, few studies have examined the effect of varying the distribution of daily protein intake 
on protein synthesis, with the limited data available confined to the nitrogen balance technique which 
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fails to provide information on protein synthesis in specific protein pools and is subject to substantial 
errors of measurement (WHO 2007).  
Typically, studies in the area of daily protein distribution have compared nitrogen retention  
when total daily protein intake is divided between several meals (Table 1.1) (Arnal et al. 1999; Arnal 
et al. 2000; Barja et al. 1972; el-Khoury et al. 1994; el-Khoury et al. 1995; Leverton and Gram 1949; 
Leverton et al. 1951; Taylor et al. 1973; Wu and Wu 1950). Most studies have shown higher nitrogen 
retention when moderate protein feeding is distributed across three (Leverton and Gram 1949; 
Leverton et al. 1951; Taylor et al. 1973) or four (Barja et al. 1972; Wu and Wu 1950) rather than only 
two  meals.  Moreover, distributing meals into more than two feedings has been shown to be superior 
for nitrogen retention even when the daily protein intake was not equally dispersed between meals  
(Leverton and Gram 1949; Leverton et al. 1951). However, distributing the daily protein intake as 
regular ingestion of 10 small meals was shown to result in lower whole body leucine balance 
compared to three discrete meals with a more prolonged post-prandial period between feeding (el-
Khoury et al. 1994; el-Khoury et al. 1995). Of note, two studies have also shown either a negative 
effect (Arnal et al. 1999) or negligible differences (Arnal et al. 2000) in nitrogen balance with 
ingestion of four iso-nitrogenous meals compared to 80% of daily protein intake in a single midday 
meal.
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Table 1.1 Studies assessing the effect of daily protein distribution on protein retention. bal, balance; B, Breakfast; BM, Body Mass; D, Dinner; EI, Energy 
Intake; F, Female; FFM, Fat free mass; Leu, Leucine; L, Lunch; M, Male; N, Nitrogen; S, snack between two meals. *= not reported, calculated based on 
average values reported on study results, subject to calculation inaccuracy. †= Same as * but using range values reported, likely less accurate than *. 
 
Study Population Protein distribution
Duration 
(days)
Prot (g • kg FFM-1 • 
day 
-1
)
Prot (g • kg 
FFM
-1 • day -1)
Prot 
(g)
Source Exercise Technique
EI (kg • 
BM
-1
)
EI (kg • 
FFM
-1
)
Results
Arnal et al. AJCN  '99
68 y                
F (n=15)
PULSE (Prot 80% L, 20% B & D)                                                         
vs. SPREAD (prot every 4 h)
14 1.05 1.7 66*
meat,fish,dairy, 
gravy, wheat
No N bal 30* 48
↑N, FFM on 
PULSE
Arnal et al. JN  '00
26 y               
F (n=16)
PULSE (Prot 80% L, 20% B & D)                                                       
vs. SPREAD (prot every 4 h)                    
14 1.24 1.7 69*
meat,fish,dairy, 
gravy, wheat
No N bal 34* 49* No differences
Barja et al. AJCN  '72
8-13 y            
(n=8)
2 (B,L) vs. 4 (B,L,S,D)  meals 7 2* --- 63
milk, meat, fish, 
egg
Yes N bal 61* --- ↑N on 4 meals
El-Khouri et al.                
AJCN  '94 & '95
23 & 21  y         
M & F             
(n= 5 + 6)
3 (B,L,D) vs. 10 pulses (every 1 h) 1 1.1 --- 56-105 Amino acid mixture No
L-[13C]-
Leu;    
[15N]urea
45 ---
↑ Leu,  lower 
urea on 3 meals
Leverton et al. JN  '49
17-27 y          
F (n=14)
2(L, D), vs. 3 (B,L,D) meals 18 0.89-1.24† --- 63
90% from meat & 
dairy
No N bal 34† --- ↑ N on 3 meals
Leverton et al. JN  '51
17-23 y            
F (n=8+8)
2(B, D), vs. 3 (B,L,D) meals 18 (0.7-0.9) / (1-1.4)† --- 43 / 63 milk, meat, egg No N bal 28-39† ---
↑N on 3 meals 
low prot
Taylor et al. AJCN  '73
19 y              
M (n=14)
2 (L, D) vs. 3 (B,L,D) meals 15 0.4 (n=7) / 0.5 (n=7) --- 29 / 34 skim milk No N bal 49 ---
↑ weight on 3 
prot meals, No 
diff N
Wu et al. EBM  '50 M (n=1) 2(B,D) vs. 4 (B,L,S,D)  meals 4 0.73 / 1.14 --- 50 / 73
Eggs, ham, milk, 
weat, rice
No N bal 34 ---
↑ N on 4 meals 
high prot
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The early study of Arnal and colleagues (Arnal et al. 1999) in which equal distribution of 
protein across daily meals showed  no beneficial effect on nitrogen balance included an elderly cohort 
of subjects and daily protein intake  at the low end (1.05 g∙kg-1 body mass) of the recommended 1-1.2 
g∙kg-1 body mass for the elderly (Bauer et al. 2013). Intuitively, the amount of protein provided in four 
equal sized meals (0.25 g∙kg-1 body mass) may have been insufficient to generate maximal rates of 
protein synthesis given older populations may require greater total protein intakes to generate positive 
net protein balance (Burd et al. 2011a; Pennings et al. 2012). However, a subsequent study by Arnal 
and co-workers (Arnal et al. 2000) utilised protein intakes above the recommended dietary allowance 
for younger subjects (Rand et al. 2003), and that also failed to show a beneficial effect of four equal 
sized meals on nitrogen retention. Of note, the higher total daily protein intake (1.25 g∙kg-1 body 
mass) may have ameliorated some of the potentially beneficial effects of equal distribution of protein 
across the day compared with 80% of total daily intake in one meal. Consequently, there is still no 
consensus regarding the optimal interplay between quantity and timing of daily protein intake. 
 
1.3.2 Timing of protein ingestion: before, during and after exercise 
 
The theory that it is possible to ‘prime’ the body’s capacity for elevated rates of muscle protein 
synthesis induced by resistance exercise by ensuring the ready availability of amino acids post 
exercise has led to numerous investigations on the effect of protein intake in close proximity to a 
resistance exercise bout (Beelen et al. 2008; Burke et al. 2012a; Fujita et al. 2009; Tipton et al. 2007; 
Tipton et al. 2001; Witard et al. 2009). Studies comparing protein ingestion prior to exercise with its 
effect at rest have shown a beneficial effect on muscle protein synthesis (Witard et al. 2009) but no 
difference has been observed with pre-exercise protein compared to placebo ingestion and exercise  
(Fujita et al. 2009). 
Beelen and colleagues have utilised a prolonged exercise session (~2 h) incorporating both 
endurance and resistance exercise modes and shown that regular provision of carbohydrate and 
protein throughout exercise was superior to carbohydrate only for increasing muscle protein synthesis 
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(Beelen et al. 2008). Despite the capacity of protein ingestion during exercise to enhance rates of 
protein synthesis the increase in energy expenditure by contraction likely prevents attainment of 
maximal rates of protein synthesis (Atherton and Rennie 2009) and direct comparison with post-
exercise protein ingestion has not been made.  
Finally, Burke and co-workers determined the effect of pre-exercise protein intake as a large 
bolus compared with a pulsed ingestion regimen that began prior to exercise but was completed ~120 
min after exercise (Burke et al. 2012a). The alternate ingestion protocols generated divergence in 
post-exercise hyperaminoacidemia but the treatments were equally beneficial for stimulating muscle 
protein synthesis compared to placebo. Interestingly, the pre-exercise protein ingestion protocols 
(bolus vs. pulse) utilised by Burke and co-workers (2012a) is essentially the same as the post-exercise 
comparison used by West and colleagues (2011). Given the post-exercise bolus ingestion elicited a 
higher rate of muscle protein synthesis than pulsed feeding this may suggest that post-exercise protein 
intake is more beneficial than pre-exercise.   
 
Few studies have examined the effect of delaying post-exercise protein ingestion on muscle 
protein synthesis. Rasmussen and colleagues have shown that a delay (3 h) in protein ingestion after 
an acute bout of resistance exercise is capable of stimulating comparable rates of muscle protein 
synthesis over a 3 h period as protein ingested 1 h post-exercise (Rasmussen et al. 2000). However,  
chronic resistance training and protein supplementation interventions in young (Cribb and Hayes 
2006), elderly (Esmarck et al. 2001) and subjects recovering from prolonged bed-rest (Brooks et al. 
2008) show increases in strength, lean body mass and muscle fibre cross sectional area when protein 
supplementation was implemented in close proximity to resistance exercise rather than delayed. 
Consequently, as there is limited evidence supporting the ingestion of a bolus of protein in close 
proximity to completion of an exercise bout, more work is needed to clearly elucidate the effect of 
different types and amount of proteins and the interaction with timing of ingestion on regulation of 
protein balance in humans. Nonetheless, the available evidence suggests that post exercise protein 
 30 
 
ingestion is more beneficial than pre-exercise protein ingestion, for inducing maximal rates of muscle 
protein synthesis (Burd et al. 2009; Drummond et al. 2009; Koopman et al. 2007b; Phillips et al. 
2009; Phillips and Van Loon 2011). 
1.4 Energy deficit and muscle mass 
Diet and exercise induced energy deficit are lifestyle strategies that promote “weight loss" and 
associated health benefits in the overweight population (Oreopoulos et al. 2010; Ross and Janiszewski 
2008).  For many athletes instead, weight loss seeks to improve lean mass to fat mass ratio, which is 
an important factor affecting performance (Fogelholm 1994a; Fogelholm 1994b; Garthe et al. 2011b; 
Morton et al. 2010). Therefore, the primary aim of weight loss is to reduce fat mass, but restricting 
dietary energy intake below energy balance generally results in the loss of ~75% fat mass and ~25% 
fat free mass (Garrow and Summerbell 1995; Weinheimer et al. 2010). Fat free mass is composed of 
~45% skeletal muscle (Müller et al. 2002) (Figure 1.13), and loss of muscle mass has a negative effect 
on resting metabolic rate (Johnstone et al. 2005), glucose and fat metabolism (Hawley and Lessard 
2008; Lewis et al. 2002; Samuel et al. 2010), locomotion (Karagounis and Hawley 2010) and athletic 
performance (Fogelholm 1994b; Garthe et al. 2011a). A decrease in muscle mass may also accelerate 
development of sarcopenia (Goodpaster et al. 2006) and sarcopenic obesity (Parr et al. 2013). 
Consequently, it is paramount that “healthy weight loss” seeks to specifically target a reduction in fat 
mass together with maintenance of skeletal muscle mass. Therefore, manipulation of exercise and 
nutrition represent key factors in any strategic approach to weight loss in general and athletic 
populations. 
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Figure 1.13 Diagrammatic representation of the major components of total fat free mass (FFM) and 
their contribution to resting energy expenditure (REE). Redrawn from (Müller et al. 2002). 
 
1.4.1 Metabolic effects of energy deficit: relationship with skeletal muscle 
 
Studies directly quantifying rates of skeletal muscle protein synthesis in a state of whole-body energy 
deprivation are limited. Energy deficit may modulate rates of muscle protein synthesis through 
changes such as decreased energy availability, metabolic compensation and up regulation of 
proteolysis. This section will provide a review of studies of the physiological effects of energy deficit 
and the capacity for resistance exercise and increased protein availability to attenuate the deleterious 
effect of energy restriction on fat free mass. 
1.4.1.1 Energy availability  
 
Negative energy balance is defined as a decrease in energy intake below the total energy expenditure.  
Indeed, the result from decreased energy intake relative to total energy expenditure is expected to 
determine subsequent weight loss. However, this approach fails to account for the body’s energy 
requirements to maintain homeostasis which is more closely related to the concept of energy 
50 
4 
44 
56 
6 
40 
Percent of total FFM Percent contribution to REE
Fat Free Mass (FFM) 
Brain, heart, liver, kidney (468 kcal • kg-1 FFM• day-1) 
Skeletal muscle (15 kcal • kg-1 FFM • day-1) 
Bone, extracellular mass (1 kcal • kg-1 FFM • day-1) 
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availability (Loucks and Callister 1993; Loucks et al. 2011; Schneider and Wade 1990). Energy 
availability is defined as the difference between energy intake and exercise/activity energy 
expenditure (Loucks and Callister 1993), that determines the energy from food available for use to 
maintain homeostasis (Loucks et al. 2011).  
It is not within the scope of this review to comprehensively discuss the concept of energy 
availability. However, its relevance and impact on studies of dietary and exercise induced weight loss 
should be highlighted. The energy availability concept has been used to elucidate the relationship 
between energy expenditure with exercise, energy intake and energy balance and their effects on the 
menstrual cycle  (Loucks and Thuma 2003), bone metabolism (Ihle and Loucks 2004), and leptin 
(Borer et al. 2009; Hilton and Loucks 2000) and ghrelin concentrations (Borer et al. 2009; Scheid et 
al. 2011). The importance of the energy availability concept is found in the different limits/thresholds 
of energy availability that affect the homeostasis of different physiological variables. For example, 
osteocalcin (OC) and type I procollagen carboxyl-terminal propeptide (PICP) are markers of bone 
formation that decrease  when energy availability falls below 45 kcal • kg FFM-1 • day-1 (Ihle and 
Loucks 2004), while luteinizing hormone pulsatility is only altered when available energy is ≤30 kcal 
• kg FFM-1 • day-1 (Loucks and Thuma 2003). Similarly, the cross-linked N-telopeptide (NTX), a 
marker of bone reabsorption, is only increased when energy availability falls to  20 kcal • kg FFM-1 • 
day
-1
 (Ihle and Loucks 2004). Importantly, no studies have compared the potential divergent effects 
when using dietary interventions for energy deficit predicated on the energy balance versus energy 
availability calculations, including studies of whole body or skeletal muscle protein synthesis. 
Accordingly, a limitation of the available literature determining the effect of energy deficit on muscle 
protein synthesis is that it is based solely on the energy deficit concept. 
1.4.1.2 Metabolic compensation 
 
Chronic energy deficit usually results in a reduced total energy expenditure due, at least in part, to 
decreased dietary-induced thermogenesis and resting metabolic rate. During periods of energy deficit 
resting metabolic rate is reduced via loss of metabolically active tissues (Johnstone et al. 2005; 
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Schwartz et al. 2012) and adaptive thermogenesis (Byrne et al. 2012). Adaptive thermogenesis can be 
defined as the reduction in resting energy expenditure that is greater than that accounted for by the 
loss of tissue and the resultant energy expenditure per unit of tissue during energy deficit (Byrne et al. 
2012; Grande et al. 1958; Johannsen et al. 2012; Weinsier et al. 2000). Given the significant 
contribution of skeletal muscle to resting metabolic rate (Müller et al. 2002) (Figure 1.13) and that 
skeletal muscle protein synthesis decreases in energy deficit (Pasiakos et al. 2010), it appears the 
metabolic status of skeletal muscle is a major contributor to adaptive thermogenesis. Therefore, 
maintaining the metabolic status of the skeletal muscle using exercise and nutrient stimuli during 
periods of chronic energy deficit may promote weight (fat) loss more comparable to theoretical 
models of expected weight loss concomitant with muscle mass retention (Byrne et al. 2012).    
1.4.1.3 Proteolysis and nitrogen balance 
 
Energy deficit induced proteolysis and loss of tissue in humans has been intensely investigated for 
decades, dating back to the World War two era and the so-called ‘Minnesota semi-starvation 
experiment’  (Kalm and Semba 2005; Keys et al. 1950). Subsequently,  researchers have attempted to 
characterize whole body protein metabolism in response to fasting (Jensen et al. 1988; Knapik et al. 
1991; Nair et al. 1987; Tsalikian et al. 1984) and energy deficit (Biolo et al. 2007; Calloway 1975; 
Calloway and Spector 1954; Friedlander et al. 2005; Gallagher et al. 2000; Hoffer et al. 1984; Hoffer 
and Forse 1990; Stanko et al. 1992). The majority of studies determining the effect of energy deficit 
on protein metabolism have used measures of nitrogen balance and leucine flux (which, in the fasted 
state, is considered equivalent to protein breakdown (Matthews et al. 1980)) to estimate whole body 
proteolysis. Generally, the results of these studies have shown that during short periods (30-72 h) of 
fasting leucine flux increases in a manner indicative of elevated whole body proteolysis (Jensen et al. 
1988; Knapik et al. 1991; Nair et al. 1987; Tsalikian et al. 1984). However, during prolonged fasting 
for up to 3 weeks and with extended periods of energy deficit (2-16 weeks) leucine flux has been 
shown to decrease (Hoffer et al. 1984; Hoffer and Forse 1990) or remain unchanged (Biolo et al. 
2007; Friedlander et al. 2005; Gallagher et al. 2000; Stanko et al. 1992). A key consideration that 
highlights the methodological limitations in quantifying whole body proteolysis is that Nitrogen 
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balance can remain negative during energy deficit while leucine flux is unchanged or decreased 
(Friedlander et al. 2005; Hoffer et al. 1984; Hoffer and Forse 1990). Despite the limitations in 
estimates of protein degradation, studies report an increased rate of nitrogen loss in the early period of 
energy deficit but a return to resting levels during  the later stages of chronic interventions (Hoffer et 
al. 1984; Hoffer and Forse 1990; Pasiakos et al. 2013; Stanko et al. 1992). Intuitively, while an initial 
increase in proteolysis with acute energy deficit may be a rapid response to maintain energy 
homeostasis, a primary adjustment of the physiological systems of the body in response to prolonged 
energy deprivation is to reduce the activity of catabolic pathways and subsequent protein turnover as a 
protective or survival mechanism. 
1.4.2 Protecting fat free mass: role of resistance exercise and dietary protein  
 
It is well-established that resistance exercise and protein ingestion combine to synergistically up-
regulate acute muscle protein synthesis in energy balance (Biolo et al. 1997; Burd et al. 2011b; 
Cermak et al. 2012; Koopman et al. 2005; Moore et al. 2009a; Moore et al. 2009b; Pennings et al. 
2011b; Yang et al. 2012b). To date, no studies have assessed the effect of energy deficit on the acute 
muscle protein synthetic response to resistance exercise and protein ingestion. However, chronic 
studies have determined the independent and combined effect of resistance training and protein intake 
during energy deficit for preventing loss of fat free mass. A meta-analysis of 87 studies has shown 
that an increase in protein intake above 1.05 g∙ kg BM-1∙day-1 during energy deficit enhances fat free 
mass retention (Krieger et al. 2006). Therefore, the quantity of nitrogen intake from protein as a 
component of total energy intake is an independent factor influencing nitrogen retention (Calloway 
1975; Calloway and Spector 1954; Leverton et al. 1951). Furthermore, nitrogen retention is dependent 
on both nitrogen and total energy intake such that at a given (fixed) amount of nitrogen ingestion a 
decrease in total energy intake may become the limiting factor. Conversely, at a sustained level of 
energy deficit the total amount of nitrogen ingestion may become the limiting factor for nitrogen 
retention (Calloway and Spector 1954; Leverton et al. 1951). Moreover, protein intake has some 
capacity to mitigate the deleterious effects of reduced energy intake on nitrogen retention (Calloway 
and Spector 1954; Leverton et al. 1951). Additionally, resistance training without specific dietary 
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intervention has also been shown to attenuate an energy deficit-induced reduction in fat free mass 
(Ballor and Poehlman 1994; Ballor et al. 1988; Campbell et al. 2009; Hunter et al. 2008; Johannsen et 
al. 2012; Layman et al. 2005; Ryan et al. 1995; Weinheimer et al. 2010). Thus, their concomitant use 
would be expected to promote maintenance of fat free mass while decreasing fat mass. When in 
energy balance, resistance training improves the capacity to retain nitrogen (Campbell et al. 2002; 
Moore et al. 2007). 
Accordingly, the use of resistance exercise and protein consumed above recommended 
dietary intakes shows an additive effect in the capacity to blunt loss of fat free mass as a result of 
chronic energy deficit (Ballor et al. 1988; Josse et al. 2011; Layman et al. 2005; Meckling and 
Sherfey 2007; Mettler et al. 2010). The addition of exercise and increased protein intake maintains 
(Josse et al. 2011; Layman et al. 2005; Meckling and Sherfey 2007; Mettler et al. 2010)  or increases 
(Ballor et al. 1988; Josse et al. 2011) fat free mass in young obese-overweight  and adult-overweight 
and lean, athletic subjects (Layman et al. 2005; Meckling and Sherfey 2007; Mettler et al. 2010) 
during energy deficit. Studies reporting maintenance of skeletal muscle mass in energy deficit have 
typically used energy restriction of 500 and 1000 kcal per day (below calculated energy balance) and 
‘high protein’ treatments approaching twice the RDI. Taken together, the results of these studies 
indicate that the maintenance of skeletal muscle during chronic energy deficit may require higher 
protein doses to elicit comparable responses to energy balance, although the possibility exists that 
muscle under energy deficit could be more responsive to transient periods of hyperaminoacidemia 
after a bout of resistance exercise.  
 
1.4.3 Effect of energy deficit and protein availability on muscle protein synthesis 
 
Despite a number studies investigating changes in fat free mass in response to diet induced energy 
deficit and effects of exercise and protein intake, studies incorporating direct measures of muscle 
protein synthesis during energy deficit are limited (Table 1.2) (Campbell et al. 2009; Pasiakos et al. 
2013; Pasiakos et al. 2010; Villareal et al. 2012).  
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Table 1.2 Studies assessing the effect of energy restriction on muscle protein synthesis. ~, unchanged. BW, Body Weight; EB, Energy Balance; ED, Energy 
Deficit; F, Females; FFM, Fat Free Mass; FM, Fat Mass; FSR, Fractional Synthetic Rate; M, Males; REX, Resistance Exercise; WL, Weight Loss. *= not 
reported, calculated based on average values reported on study results, subject to calculation inaccuracy. 
 
Study Subjects Population
ED(kcal • 
d
-1
)
Time 
ED 
(days)
Exercise
ED prot intake 
(kcal • kg BM-1• 
day
-1
)
 ED prot intake 
(1 kcal • kg 
FFM
-1 • day-1)
FFM loss FM loss
Resting 
FSR
Conclusions
Campbell et al. Ob  '09
 ~69 y              
F (n=16)
Overweight 500 77
Yes & No 
(REX)
1 1.9*
0.5 & 4.2 % 
BW
12.8/12.1 % 
BW
↑ >100 % 
 Resting FSR ↑during EB 
after ED
Pasiakos et al. FASEB  '13
21 y             
M& F (n= 39)
Healthy fit ~500 21
Yes (REX, 
END)
0.8/1.6/2.4 --
58/30/36 % 
WL
42/70/64 % WL ~
ED does not affect resting 
FSR
Pasiakos et al. JN  '10
21 y                
M & F (n=12)
Healthy fit 500 10 Uncontrolled 1.5 1.9* -- -- ↓ 19 %  ED ↓ resting FSR
Villareal et al. Ob  '11
69 y                
M & F (n=8)
Obese 500-750 90 No 1 1.8* 2.6 % BW * 4.6 % BW* ~
ED does not affect resting 
FSR
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Pasiakos and colleagues (2010) (Figure 1.14) have undertaken the only energy deficit study in 
humans to show a decrease in resting FSR in skeletal muscle. Specifically, young healthy, physically 
active men undertook 10 days of energy deficit (~500 kcal∙day-1) that reduced resting mixed muscle 
FSR ~19%, similar to the results of studies in energy restricted rodent skeletal muscle (Clark and 
Mitch 1983; Dunn et al. 1982; Goodman et al. 1981). Other studies in humans utilising longer periods 
of energy deficit (21 and 90 days) found no alteration in the rate of muscle protein synthesis at rest 
when compared to energy balance (Pasiakos et al. 2013; Villareal et al. 2012). In contrast, Campbell 
and colleagues (Campbell et al. 2009) have shown elevated (>100%) resting muscle FSR after 11 
weeks of energy deficit. However, an important consideration of that study was that at the conclusion 
of the experimental period quantification of FSR occurred after subjects returned to energy balance 
for one week. Consequently, it may be that returning to  energy balance after chronic energy deficit 
generates a significant up-regulation of resting muscle protein synthesis that is solely attributable to 
changes in the metabolic response that occur with alterations in energy availability. 
 
Figure 1.14 Effect of energy deficit on resting muscle protein synthesis (* P<0.05 vs EB). Adapted 
from (Pasiakos et al. 2010). 
There are several confounding factors that may account for the differences between human 
studies showing variation in resting MPS after energy deficit (Pasiakos et al. 2013; Pasiakos et al. 
2010; Villareal et al. 2012). The original study of Pasiakos and co-workers showing a decrease in 
resting skeletal muscle FSR following energy deficit did not include any exercise intervention but 
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their subsequent study incorporated aerobic and resistance exercise during the period of  energy 
deficit (Pasiakos et al. 2013; Pasiakos et al. 2010). Considering exercise promotes maintenance of 
FFM (Ballor and Poehlman 1994; Garrow and Summerbell 1995; Weinheimer et al. 2010) this likely 
explains the lack of change in rates of resting muscle protein synthesis.  
Chronic resistance training (8 weeks) has been shown to increase resting mixed muscle 
protein synthesis in the fasted, but not fed, state when subjects were presumed to remain in energy 
balance throughout the experimental period (Kim et al. 2005; Tang et al. 2008). It is still unclear how 
chronic energy deficit might alter rates of muscle protein synthesis induced by resistance training and 
whether the quantification of FSR following energy deficit is undertaken in the fed or fasted state may 
also dictate the protein synthetic response. Villareal and colleagues (Villareal et al. 2012) report 
comparable post-absorptive rates of resting muscle protein synthesis after chronic diet-induced energy 
deficit (500-750 kcal ∙ day-1) without an exercise intervention in an obese subject cohort. Protein 
intake during their 3 month intervention period was calculated using 1 g ∙ kg body mass-1 ∙ day-1 and 
the high fat mass: fat free mass ratio (~55% FM: 45% FFM) in their subject cohort dictated that 
subjects relative protein intake was ~2 g ∙ kg fat free mass-1 ∙ day-1. Therefore, given that protein 
intake is likely to impact skeletal muscle protein metabolism and rates of protein synthesis the high 
protein intake may have been an important factor contributing to maintenance of resting muscle 
protein synthesis after chronic energy deficit.  
If increased protein intake can prevent the energy deficit induced loss of fat free mass 
(Krieger et al. 2006) and more specifically skeletal muscle mass, does energy deficit enhance or 
attenuate the acute muscle protein synthetic response to amino acid provision? The studies of 
Villareal and colleagues and Pasiakos and co-workers provide some information on fed state rates of 
muscle protein synthesis after energy deficit but report conflicting results (Figure 1.15) (Pasiakos et 
al. 2013; Villareal et al. 2012). 
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Figure 1.15 Effect of protein ingestion after chronic energy deficit on mixed muscle protein 
synthesis. (A) Refer to (Villareal et al. 2012) “Fig 1” ; (B) Refer to (Pasiakos et al. 2013) “Fig. 3 D”  
 
Villareal and colleagues (2012) reported an increase in muscle protein FSR  following 10-15 
g protein ingestion after 3 months energy deficit (Figure 1.15 A). Surprisingly, in this study there was 
no change in muscle protein synthesis with protein ingestion when subjects were in energy balance. 
The study design utilised a pulsed feeding protocol of small boluses every 10 minutes throughout 2.5 
h which generated a minimal increase in leucinemia (~1.15 fold). Consequently, the metabolic state of 
the muscle in chronic energy deficit may have resulted in an anabolic response regardless of the 
feeding protocol but the lack of a pronounced leucinemia may have prevented an increase in protein 
synthesis in energy balance (Cuthbertson et al. 2005; Pennings et al. 2012; Yang et al. 2012a; Yang et 
al. 2012b). Nevertheless, prolonged exposure to energy deficit enhanced the muscle protein synthetic 
response to amino acid provision and may indicate an increase in muscle “sensitivity” to amino acid 
availability with energy deficit. In contrast, Pasiakos and colleagues (2013) have shown a protein 
containing meal (20 g protein) elevates post-prandial muscle protein synthesis following 21 days 
energy deficit but only with dietary protein intakes at three times the RDA for protein during energy 
deficit (Figure 1.15 B). Whether the differences between studies are a result of different populations, 
diet and acute feeding patterns, duration of energy deficit or exercise remains unclear. However, in 
rodent models of fasting the duration of  energy restriction, and relative age and adiposity have each 
been identified as factors capable of modulating the rates of protein synthesis and breakdown in 
response to fasting (Goodman et al. 1981), with circulating lipid availability being an important factor 
determining rates of myofibrillar protein breakdown (Lowell and Goodman 1987). Whether 
comparable effects are evident in humans is a fertile area for future research. 
In summary, while empirical evidence of the effect of energy deficit on skeletal muscle 
protein metabolism is lacking it appears that after an early period of depressed resting muscle protein 
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synthesis (Pasiakos et al. 2010) a metabolic adjustment may occur to  return protein synthesis to basal 
or energy balance values (Pasiakos et al. 2013; Villareal et al. 2012). Importantly, the absence of 
studies directly quantifying muscle protein breakdown prevents a comprehensive understanding of the 
mechanisms and time course regulating skeletal muscle mass and the locus of control of protein 
turnover during energy deficit. Nonetheless, protein intake and exercise represent key factors for the 
maintenance of muscle mass during energy deficit and appear to be equally important for modulating 
rates of protein synthesis in energy deficit as in energy balance.  
 
1.5 Summary and aims of the thesis 
Increasing skeletal muscle mass is key for health and performance in several sports, and resistance 
exercise and protein intake are synergistic in their capacity to promote myofibrillar protein synthesis. 
The pattern of dietary protein delivery is a factor that includes a plethora of variables with potential to 
maximize maintenance or gains in muscle mass. Within the dietary protein amino acid pool, leucine is 
unique in its capacity to promote an anabolic state at the cellular and whole body level. Despite this 
fact, current knowledge of the effects of different concentrations of leucine on cell signalling and 
protein synthesis is deficient. Nonetheless, the anabolic effect of amino acids on skeletal muscle can 
be maximized via a resistance exercise mediated increase in sensitivity to amino acid provision, an 
effect that is evident for ~24 h. Nitrogen retention may also be enhanced when protein is ingested in 
three or four daily meals but the effect of daily protein distribution on muscle protein synthesis during 
the ‘window of enhanced muscle anabolic response’ induced by resistance exercise is not known.  
Dietary energy deficit generates changes in whole body net protein balance that result in a 
catabolic state. Consequently, a consequence of ‘classic’ dietary weight loss interventions is loss of 
fat free mass, which appears to be due, at least in part, to down-regulation of muscle protein synthesis. 
In light of the health and sports performance benefits of reducing fat mass while maintaining muscle 
mass, avoiding the energy deficit induced loss of muscle mass is of foremost importance. Chronic 
studies indicate that resistance exercise and increased dietary protein intake are stimuli capable of 
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mitigating the energy deficit induced fat free mass loss. However, their capacity to modulate factors 
regulating muscle protein synthesis during energy deficit is currently unknown.   
Our understanding of the effects of dietary protein intake and exercise-nutrient interactions on 
skeletal muscle physiology remains incomplete. Consequently, the aim of the current thesis was to 
determine 1) the regulatory effect of leucine on cellular signalling mechanisms regulating the 
translational machinery and muscle protein synthesis, 2) the effect of different timing and distribution 
of protein intake on myofibrillar protein synthesis during prolonged recovery from a bout of 
resistance exercise, and 3) the regulation of myofibrillar protein synthesis by resistance exercise and 
protein ingestion during reduced energy deficit. 
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Chapter Two 
 
Effects of leucine concentration on mTOR signalling and cell size 
in C2C12 skeletal muscle cells 
 
 
 
Adapted from: José L Areta, John A Hawley, Ji-Ming Ye, M.H. Stanley Chan and Vernon G 
Coffey (2013) Amino Acids (In Review) 
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2.1 Introduction 
Leucine is a key amino acid for the control of translation initiation in muscle cells (Atherton et al. 
2010b; Deldicque et al. 2008). Increasing leucine concentration in tissue culture, alone or with other 
amino acids, activates protein synthesis (Buse and Reid 1975; Escobar et al. 2007; Fulks et al. 1975), 
whereas leucine withdrawal blunts the muscle protein synthetic response in cell culture (Kimball et al. 
1998; Talvas et al. 2006). In addition, despite the capacity for other amino acids to independently 
enhance the phosphorylation status  of specific translation initiation proteins (such as 4E-BP1, p70S6k 
and rpS6), the effect of leucine is consistently superior (Atherton et al. 2010b).  
The mechanistic target of rapamycin (mTOR) complex 1 (mTORC1) has emerged as a focal 
point for nutrient sensing of amino acids in skeletal muscle (Dibble and Manning 2013; Rivas et al. 
2009a). The key role for mTORC1 in mediating amino acid-induced cell signalling is supported by 
the result of studies showing the increase in translation initiation stimulated by amino acids is down-
regulated by the mTOR antagonist rapamycin (Haegens et al. 2012; Hara et al. 1998; Vary et al. 
2007). mTORC1 initiates its downstream effects through phosphorylation of its primary targets the 
p70 S6 kinase (p70S6K) and eukaryotic initiation factor 4E-binding protein 1 (4EBP1), proteins 
acting proximal to translation. p70S6k acts through ribosomal protein S6 (rpS6) to increase the 
transcription of specific mRNAs with a polypyrimidine tract at the 5’end which encode ribosomal 
proteins (Meyuhas 2000). On the other hand phosphorylation, de-represses 4EBP1 which in turn 
allows the formation of the eukaryotic initiation factor 4F complex (eIF4F) and increases translation 
initiation (Kimball and Jefferson 2010).   
To date, studies show that protein, and particularly leucine content of meals, is a critical 
factor promoting muscle protein synthesis (Churchward-Venne et al. 2012; Cuthbertson et al. 2005; 
Escobar et al. 2007; Moore et al. 2009a; Norton et al. 2012; Pennings et al. 2012; Wall et al. 2013). 
The effect of increasing doses of leucine on p70 S6K phosphorylation in muscle cells also indicates 
the positive anabolic effects of leucine (Deldicque et al. 2008). However, there is currently a lack of 
information on the dose-dependent effects of leucine on muscle cell signalling and protein accretion. 
Further characterization is warranted due to the importance of leucine in the regulation of the 
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translational machinery. Several studies that have investigated the effect of leucine on mTOR-
mediated signalling in muscle cells have used a single concentration of leucine (Atherton et al. 2010b; 
Herningtyas et al. 2008; Mordier et al. 2000; Peyrollier et al. 2000; Tassa et al. 2003) which fails to 
capture the dosage effect of this amino acid might have on the anabolic response. Moreover, the 
relationship of leucine concentration in isolation and the resultant rate of protein synthesis in 
myotubes remains unclear (Deldicque et al. 2008; Du et al. 2007; Haegens et al. 2012).  The aim of 
the present study was to determine the effect of increasing doses of leucine on the mTOR intracellular 
signalling network, protein synthesis and cell diameter, in C2C12 muscle cells. The hypothesis was 
that a leucine threshold exists, that represents the minimum requirement to activate the signalling and 
protein synthetic machinery regulating acute and chronic protein accretion in muscle cells.  
2.2 Methods 
Cell Culture 
C2C12 myotubes originating from the American Tissue Culture Collection were used. These 
myotubes represent a suitable model to study skeletal muscle metabolism and have been shown to be 
appropriate for similar studies quantifying equivalent physiological variables to those measured in the 
current study (Atherton et al. 2010b; Haegens et al. 2012; Herningtyas et al. 2008; Martinet et al. 
2005; Mordier et al. 2000; Stevenson et al. 2005; Talvas et al. 2006; Tassa et al. 2003). The myotubes 
were incubated in DMEM containing 10% (v/v) foetal bovine serum (FBS) and antibiotic-antimycotic 
(1% v/v, Penicillin-Streptomycin, 5000 U/mL) in a 37 ᵒC, 5% CO2/95% air atmosphere. Upon 100% 
confluence, myotubes were induced to differentiate for 7 days by changing media FBS content to 2% 
while maintaining all the other variables constant. For acute leucine signalling experiments, after 7 
days of differentiation, cells were deprived of serum by incubation in serum free DMEM, followed by 
1 h incubation in a saline solution (CaCl2 0.901 mM, MgCl2 0.493mM, KCl 2.67 mM, KH2PO4 1.47 
mM, NaCl 137.93mM, Na2HPO4-7H2O 8.06 mM). Cells were treated with 0, 1.5, 3.2, 6 and 16.5 
mM leucine (L8912, Sigma-Aldrich, Australia) for 30 min as determined by a prior time-course 
experiment (data not shown).  
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Cell Diameter Measurement 
During chronic leucine exposure, differentiating cells were micrographed using methods previously 
described (Menconi et al. 2008) with a Nikon eclipse TS100 Microscope with DS-Fi 1 camera head 
and DS-L2 control unit. Magnification used was 20X, lens Nikon /0.4, Ph1 ADL∞/1.2 WD3.1. Four 
micrographs from randomly selected fields in 4 different wells were obtained every 24 h during the 7 
day differentiation process. From each micrograph 15 myotubes were measured (60 per treatment) 
using specialized software (Image J, version 1.47c, National Institutes of Health, USA). 
To determine the effects of chronic addition of leucine on cell diameter, differentiation media 
was supplemented with leucine in concentrations of 0, 0.45, 1.5, 5 and 16.1 mM and 5 mM creatine 
was used as a positive control for 7 days (Louis et al. 2004). 
First, the chronic effect of increasing doses of leucine was determined. As cell diameter 
increased when leucine was added chronically for 7 days in the differentiation media (Fig.2.5), but 
low doses of leucine (≤1.51 mM) had no effect on cell hypertrophy, the 0.45 mM treatment was 
excluded and a 3.2 mM treatment concentration was included in all subsequent experiments. 
 
Measurement of Protein Synthesis  
Radioactive phenylalanine incorporation into protein was measured in C2C12 myotubes using 
methods previously described by Smith and co-workers (1999). Seven day differentiated myotubes 
were incubated for 60 min in a FBS free media with 0, 1.51, 3.2, 5 or 16.5 mM Leucine. The media 
was then supplemented with non-radioactive and radioactive phenylalanine (75 μmol L-phenylalanine 
and 50 μCi of, L-[2,3,4,5,6-3H]-Phenylalanine/ml). At the end of the incubation, the myotubes were 
washed with ice-cold PBS three times. PBS was completely removed from the well before 1 ml of 
perchloric acid (PCA) was added and incubated at 4°C for 20 min. PCA was subsequently removed 
and 0.8 mL of 0.3 M NaOH added. The plate was then incubated at 4°C for 30 min, and a final 
incubation at 37°C for 20 min. The NaOH protein-containing solution was transferred into a fresh 
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tube before the addition of 0.8 ml of 0.3 M NaOH to extract the remaining content of the well.  0.4 ml 
of 2 M PCA was added to precipitate proteins in the NaOH solution. Tubes were then vortexed and 
chilled for 20 min. Subsequently, samples were centrifuged at 3000 g for 10 min at 4°C. The pellet 
was dissolved using 1 ml of 0.3 M NaOH. A small aliquot was used to measure protein concentration 
using bicinchoninic acid (BCA) assay (Pierce, Rockford, IL, USA), while a separate  aliquot of 500 μl 
was subjected to liquid scintillation counting  (Tri-Carb 2810TR, Perkin Elmer Pty Ltd, US). 
 
Immunoblotting  
Cells lysates were homogenised in ice-cold extraction buffer containing 65 mM Tris (pH 7.4), 150 
mM NaCl, 5mM EDTA, 1% NP-40, 0.5% Na-deoxycholate, 0.1% SDS, 10% glycerol. Protease 
inhibitor cocktail was added to the buffer in a 1:100 ratio (Sigma, Australia). Phosphatase inhibitors 
10 mM NaF, 1mM Na3VO4, and 1 mM PMSF were also used. Homogenates were centrifuged at 
10,000 g for 15 min at 4ᵒC before recovery of supernatants representing sarcoplasmic fractions.  BCA 
assay, (described above) was used to determine sarcoplasmic protein concentration. Lysate was re-
suspended in Laemmli sample buffer. In each well of a SDS polyacrylamide gel, 20 μg of protein 
were loaded and separated by electrophoresis, and transferred to polyvinylidine fluoride membranes 
blocked with 5% non-fat milk, washed with TBST (10 mM Tris–HCl, 100 mM NaCl, 0.02% Tween 
20) and incubated with primary antibody (1:1000) overnight at 4ᵒ C. Membranes were incubated with 
secondary antibody (1:2000) and proteins were detected via chemiluminescence (Amersham 
Biosciences, Buckinghamshire, U.K.; Pierce Biotechnology, Rockford, IL) and quantified by 
densitometry. Polyclonal anti-phospho mammalian target of rapamycin (mTOR) Ser2448 (#2971), 
p70S6k Thr421/Ser424 (#9204), p70S6K Thr 389 (#9234), ribosomal protein S6 Ser 235/6 (#4856), 
4E-BP1 Thr 37/46 (#2855), eIF2α Ser51 (#3597), eEF2 Thr56 (#2331), and anti-α-tubulin control 
protein (#3873) were purchased from Cell Signaling Technology (Danvers, MA). Polyclonal anti-
phospho- PRAS40 Thr246 (#07-888) was from Millipore (Temecula, CA). The α-tubulin was used as 
the loading control protein. 
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Statistical Analysis 
Results were analyzed using a one way ANOVA with Student-Newman-Keuls post-hoc analysis with 
significance achieved when P<0.05 (SigmaStat version 3.10). Data are presented as mean ± SEM.  
2.4 Results 
Cell signalling 
mTOR and PRAS 40. The phosphorylation of mTOR at Ser2448 was increased above control when 
treated with 1.51 (1.38 fold, P<0.02), 3.2 (1.3 fold, P<0.04), 5 (1.41 fold, P<0.02) and 16.1 (1.33 fold, 
P<0.04) mM leucine, with no differences between treatments (Figure 2.1, A). PRAS 40 had a non-
significant 1.1 fold increase in Thr246 phosphorylation above control in all treatments (Figure 2.1, B).  
 
Figure 2.1 Phosphorylation status of mTORSer2448 (A) and PRAS 40Thr246 (B) following 30 min 
exposure to 1.51, 3.2, 5 or 16.5 mM leucine, adjusted for α-tubulin content. Data were analysed using 
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a 1-way ANOVA with Student–Newman–Keuls post hoc analysis. Values are mean ± SEM (n=6); a, 
different vs control (Ct; P<0.05). 
 
p70S6k and rpS6. Leucine supplementation increased p70S6k Thr 389 phosphorylation in a dose-
response manner.  Leucine increased Thr 389 phosphorylation above control in response to 1.51 (3.61 
fold, P<0.001), 3.2 (4.16 fold, P<0.001), 5 (4.48 fold, P<0.001) and 16.1 (4.68 fold, P<0.001) mM 
leucine (Figure 2.2, A). The phosphorylation of p70S6k was further potentiated at the 5 and 16.5 mM 
concentrations compared to 1.5 mM (1.24 and 1.3 fold respectively, P<0.02). In addition, there was a 
trend (P=0.065) towards a difference between 1.51 and 3.2 mM groups. Despite this, the 
phosphorylation status of p70S6k at Ser 421/Thr424 was not significantly increased above control 
when treated with 1.51 (1.33 fold), 3.2 (1.38 fold), 5 (1.39 fold) and 16.1 (1.6 fold) mM leucine 
(Figure 2.2, B). In keeping with phosphorylation of p70S6k Thr 389, the rpS6 phosphorylation at Ser 
235/236 was increased above control in all of the following treatments: 1.51 mM (2.25 fold, 
P<0.001), 3.2 mM (2.45 fold, P<0.001 ), 5 mM (2.26 fold, P<0.001) and 16.1 mM (2.48 fold, 
P<0.001) (Figure 2.2, C), but there was no differences between treatments. 
4E-BP1, eIF2α and eEF2. 4E-BP1 phosphorylation at Thr37/46 reflected its upstream regulator 
mTOR and was increased above control with incubation of 1.51 (1.84 fold, P < 0.001), 3.2 (2 fold, P 
< 0.001), 5 (1.87 fold, P < 0.001) and 16.1 (2.05 fold, P < 0.001) mM leucine concentrations, with no 
differences between treatments (Figure 2.3, A). There was a reduction of eEF2 Thr56 phosphorylation 
in 16mM compared to control (0.84 fold) but this change failed to reach significance. Phosphorylation 
of eIF2α at Ser51 was not different with incubation of varying leucine concentrations (Figure 2.3, B 
and C). 
Representative blots are presented in Figure 2.4 
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Figure 2.2 Phosphorylation status of p70S6k Thr389 (A), p70S6k Thr421/Ser424 (B) and rpS6 
Ser235/236 (C) following 30 min exposure to 1.51, 3.2, 5 or 16.5 mM leucine, adjusted for α-tubulin 
content. Data were analysed using a 1-way ANOVA with Student–Newman–Keuls post hoc analysis. 
Values are mean ± SEM. (n=6); Different vs: a, control (Ct; P<0.001); b, 1.51 mM (P<0.02); † P = 
0.065 vs 1.51 mM. 
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Figure 2.3 Phosphorylation status of 4E-BP Thr37/46 (A), eIF2α Ser51 (B) and eEF2 Thr56 (C) 
following 30 min exposure to 1.51, 3.2, 5 or 16.5 mM leucine, adjusted for α-tubulin content. Data 
were analysed using a 1-way ANOVA with Student–Newman–Keuls post hoc analysis. Values are 
mean ± SEM (n=6); a, different vs control (Ct; P<0.05). 
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Figure 2.4 Representative blots, left column is phospho-proteins, right column is α-tubulins. 
Protein synthesis 
There was no significant effect of leucine concentrations on the incorporation of labelled 
phenylalanine into the cellular proteins (Figure 2.5). 
 
Figure 2.5- C2C12 L-[2,3,4,5,6-3H]-Phenylalanine incorporation during 60 min of exposure to 
increasing doses of leucine. Values are mean ± SEM (n=3); Ct, control. 
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Cell diameter 
After 7 days of differentiation there were no differences in the diameter of the 0.45 and 1.5 mM 
leucine concentration treatments compared to control (Figure 2.6). However, 5, 16.5 mM leucine and 
5 mM creatine treatments increased myotube size compared to control as demonstrated by the greater 
cell diameter (1.67, 1.62 and 1.63 fold respectively, P<0.001), that were also different from 0.45 
(1.57, 1.52 and 1.53 respectively, P<0.001) and 1.51 (1.6, 1.55 and 1.56 respectively, P<0.001 ) mM  
leucine treatments. 
 
Figure 2.6 C2C12 cell diameter after 7 days of differentiation into myotubes with daily change of 
media (2% FBS DMEM with 0 (Ct), 0.45, 1.51, 5 and 16.5 mM leucine, and 5 mM creatine (Cr). 
Values are mean ± SEM. * different from Ct, 0.45 and 1.51 mM P<0.001.  
2.4 Discussion 
Leucine is unique among essential amino acids due to its capacity to induce an anabolic response in 
the translational machinery and protein synthesis in skeletal muscle (Atherton et al. 2010b; Deldicque 
et al. 2008). The current study is the first to demonstrate the effect of increasing leucine concentration 
on the mTOR signalling pathway, amino acid incorporation and cell diameter, in C2C12 myotubes. 
The results demonstrate that a majority of the mTOR signalling intermediaries regulating translation 
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initiation and elongation do not display an acute dose dependent relationship with increasing leucine 
concentration. This new information indicates that chronic exposure at ≥5 mM leucine concentrations 
are required to enhance cell growth. Furthermore, these findings reveal that p70S6K is the signalling 
protein most sensitive to increasing leucine concentrations but despite increased phosphorylation 
status for mTOR-mediated signalling, acute incubation with leucine in isolation does not increase 
acute protein synthesis in myotubes.  
The addition of leucine to C2C12 myotubes in the range of concentrations induced a similar 
increase in phosphorylation of the specific proteins quantified. The data indicate that even the lowest 
leucine concentration (1.5 mM) was capable of eliciting a maximal phosphorylation response of key 
mTORC1 signalling proteins (Figs 2.1-2.3). Interestingly, it appears that in this in vitro model, a 
critical threshold may exist for the leucine inducible phosphorylation of mTOR-mediated signaling in 
muscle cells and that once this is surpassed, the anabolic signal plateaus. As a focal point for 
integrating Rag-GTPase, Vps34 and MAP4K3 amino acid signal transduction mTOR phosphorylation 
at Ser 2448 (1.3-1.4 fold; Fig. 2.1 A), was comparable across all leucine concentrations. The 
magnitude of phosphorylation above control was both similar and lower to that reported previously by 
others (Atherton et al. 2010b; Deldicque et al. 2008; Du et al. 2007; Gran and Cameron-Smith 2011; 
Haegens et al. 2012) (Fig. 2.1 A). Comparable increases in mTOR phosphorylation have also been 
reported with provision of different doses of insulin (Greenhaff et al. 2008) and amino acids (Areta et 
al. 2013) in in vivo human skeletal muscle. Collectively, these results suggest that while mTOR may 
act as a leucine/amino acid sensor, increasing leucine availability beyond 5 mM generates a 
diminishing response of its phosphorylation status. 
The absence of a clear dose-dependent change in phosphorylation with increasing doses of 
leucine was also observed for other proteins proximal to translation initiation. Phosphorylation of 
rpS6 Ser235/236 and 4E-BP1 Thr37/46 increased above control but was not different between the 
various leucine concentrations. The leucine-mediated increase in phosphorylation of rpS6 and 4E-BP1 
has been reported previously in vitro (Atherton et al. 2010b; Deldicque et al. 2008) but these results 
are the first to show a plateau with increasing leucine concentration. The exception from the 
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signalling data was the p70 S6K Thr389 which displayed a step-wise increase with increasing leucine 
concentration. A similar pattern was observed at Thr421/Ser424 (Fig 2.2), and it is tempting to 
speculate that leucine has the capacity to directly induce changes in p70 S6K phosphorylation, 
although further work is required to substantiate this hypothesis. Deldicque and co-workers (2008) 
have previously undertaken a leucine dose response for phosphorylation of p70S6k Thr389 in 
isolation and show the exponential rise in phosphorylation for their sigmoidal curve was initiated at 
~5 mM. Similarly, Deshmukh and colleagues (2009) failed to show an effect of leucine on Thr389 
phosphorylation at 0.5 mM, but phosphorylation of p70 S6K was augmented at 5 mM. The 
differences in magnitude of p70S6k Thr389 phosphorylation between studies are likely to reflect 
differences in the methods employed by the studies (i.e. cell type, amount and type of serum, media 
type, serum starvation protocol). Regardless, the results of the present study complement that reported 
by Deldicque and co-workers (2008) and Deshmukh and colleagues (2009) and indicate that, in vitro, 
5 mM leucine may represent a threshold that promotes substantial levels of p70 S6K activity.  
Translational control is also regulated by additional initiation and elongation factors and 
phosphorylation of eIF2α at Ser51 and eEF2 at Thr56 can potentially modulate protein synthesis 
(Kaul et al. 2011; Kimball et al. 1998; Kimball and Jefferson 2010). Atherton and colleagues (2010b) 
have previously determined the effect of all essential amino acids on translational signalling in vitro 
and showed no change in the phosphorylation status of eIF2α or eEF2 with incubation of any essential 
amino acid. This lack of change in phosphorylation has also been observed with amino acid provision 
in vivo in humans (Atherton et al. 2010a). The present study extends on these findings to show that 
the unresponsiveness of eIF2α and eEF2 phosphorylation to leucine in muscle is sustained across a 
wide range of concentrations. Accordingly, it appears that neither signalling protein fulfils its role in 
the translation machinery in a nutrient sensitive manner.  
While the mTOR-mediated signalling pathway was stimulated by leucine, the lack of change 
in eIF2α or eEF2 indicates leucine treatment did not result in up regulation of the global translational 
machinery and may explain, in part, the absence of acute increases in rates of protein synthesis. 
Previous cell culture studies show contrasting effects where leucine has been shown to increase 
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protein synthesis in some (Du et al. 2007; Kimball et al. 1999) but not all studies (Deldicque et al. 
2008; Haegens et al. 2012). Kimball and colleagues (1999) showed leucine increased protein 
synthesis compared to a leucine deprived condition but was not greater than  control. In addition, Du 
and colleagues (2007) have also shown increases in protein synthesis with leucine treatment but the 
protocol used in their study was unique in that cells were incubated in a 0.2% FBS media when 
treated with leucine. In contrast to the acute protein synthesis data these results show an effect of 
increasing leucine concentration on myotube diameter (Fig. 2.5). Specifically, there was a larger cell 
diameter compared with control, 0.45 and 1.51 mM in the 5 mM and 16.5 mM treatments. An 
important distinction between the acute and chronic leucine experiments was that the chronically 
differentiating myoblasts were exposed to 2% FBS, whereas during the acute tracer incorporation 
FBS was absent. The nutrient, growth factor and hormone content of the serum has the capacity to 
modulate cell growth (Lee et al. 2011) and may have been permissive for protein synthesis and 
growth. Therefore, the cellular milieu in the chronic intervention permitted the physiological effect of 
different leucine concentrations to be evident, while any potential effect on acute protein synthesis 
was blunted without the requisite amino acids and growth factors to synthesize new protein. 
Regardless, these results show that a critical threshold for enhancing cell diameter in vitro occurred 
between 1.5 and 5 mM leucine concentration. 
In conclusion, these results provide new information showing that phosphorylation of mTOR 
signalling pathway intermediaries involved in regulating translation initiation is enhanced in vitro 
even at low leucine concentrations. Of the signalling proteins quantified in the present study p70S6k 
Thr389 phosphorylation alone appears to follow a modest leucine dose-response relationship where 
increasing concentration of leucine induces a greater magnitude of phosphorylation but this occurred 
in the absence of acute protein synthesis. Chronic exposure to lower concentrations of leucine (≤1.51 
mM) fail to increase cell diameter of C2C12 myotubes but leucine concentrations ≥5 mM augment 
rates of protein accretion and may represent a threshold for enhanced cell growth. These findings 
collectively support the hypothesis that a leucine threshold exists that represents the minimum 
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requirement to activate the signalling and protein synthetic machinery regulating acute and chronic 
protein accretion in muscle cells. 
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Chapter Three 
 
Timing and distribution of protein ingestion during prolonged 
recovery from resistance exercise alters myofibrillar protein 
synthesis 
 
 
Adapted from: Areta JL, Burke LM, Ross ML, Camera DM, West DWD, Broad EM, 
Jeacocke NA, Moore DR, Stellingwerff T, Phillips SM, Hawley JA, Coffey VG, (2013). The 
Journal of Physiology 591 (9):2319-2331. doi:10.1113/jphysiol.2012.244897 
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3.1 Introduction 
Skeletal muscle protein synthesis is stimulated by exercise (Biolo et al. 1995b; Chesley et al. 1992; 
Phillips et al. 1997) and protein feeding (Cuthbertson et al. 2005; Rennie et al. 1982). When feeding 
follows exercise the effect is enhanced (Moore et al. 2009a; Moore et al. 2009b) and promotes 
positive net protein balance in skeletal muscle (Phillips et al. 1997). Although the majority of studies 
of exercise and protein ingestion have characterized the response to a single protein feeding over 4-6 
h of recovery (Dreyer et al. 2008; Moore et al. 2009a; Moore et al. 2009b; Tipton et al. 1999; West et 
al. 2011), it is important to note that the enhanced sensitivity of myofibrillar protein synthesis (MPS) 
to protein ingestion following resistance exercise is sustained for at least 24 h (Burd et al. 2011b).  
However, the paucity of studies measuring MPS beyond the traditional 4-6 h recovery window 
precludes our ability to prescribe an optimized spacing and amount of protein intake throughout the 
day or during a prolonged (i.e. 12 h) recovery period after resistance exercise. Such information could 
be important for enhancing skeletal muscle mass with the potential for use in a variety of populations 
including the elderly and athletes (Layman 2009; Paddon-Jones and Rasmussen 2009; Phillips and 
Van Loon 2011). 
 
Investigations during early recovery after exercise provide some insight into the potentially 
beneficial effects of longer term feeding strategies.  It is known that there is a dose-response in muscle 
protein synthesis to the intensity (Kumar et al. 2009b) and volume (Burd et al. 2010a) of exercise, as 
well as to the amount of protein consumed after exercise (Moore et al. 2009a). Specifically, muscle 
protein synthesis can be maximally stimulated by the intake of 20 g of high quality protein (Moore et 
al. 2009a), with lower doses resulting in suboptimal rates of muscle protein synthesis, and protein 
intakes above this level stimulating irreversible oxidative amino acid (AA) catabolism (Moore et al. 
2009a).  Furthermore, rates of MPS 1-5 h after a bout of resistance exercise are higher when rapid 
aminoacidemia is achieved by ingesting a bolus (25 g) of whey protein compared to a slow, moderate 
but sustained rise in blood amino acids elicited by an identical protein source consumed in a pulsed 
feeding pattern  (West et al. 2011).   Thus, the interplay of the quantity and timing of protein ingestion 
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is a major factor regulating the capacity of the muscle protein synthetic machinery to respond to 
repeated anabolic stimuli.  Importantly, elevated rates of muscle protein synthesis return to basal 
values in the resting state after 2 h of AA provision (either orally or intravenously) despite a sustained 
AA availability (Atherton et al. 2010a; Bohe et al. 2001), a phenomenon called the “muscle full” 
effect (Atherton et al. 2010a).  How rapidly the protein synthesis machinery recapitulates its capacity 
to respond to the provision of nutrients and whether there are differences in the optimal timing and 
quantities of protein necessary to repeatedly stimulate maximal skeletal muscle protein synthesis after 
a bout of resistance exercise have not been determined.  There may also be potential for exceptions to 
the “muscle full” effect under specific physiological or experimental conditions (Glover et al. 2008).  
Another important factor to consider is the capacity of exercise to extend the duration of the anabolic 
stimulus induced by feeding (Moore et al. 2009b) . Collectively, this suggests that increased 
aminoacidemia after exercise is beneficial for muscle hypertrophy response but the optimal pattern of 
aminoacidemia remains to be established.  
Therefore, the aim of the present study was to determine how the quantity and timing of 
protein ingestion after a single bout of resistance exercise influence the muscle anabolic response 
throughout the entire day. Previous studies have shown muscle protein synthesis following increased 
availability of amino acids peaks within ~2 h (Atherton et al. 2010a; Bohe et al. 2001) but cyclical 
oscillation of aminoacidemia appears to be required  to  prevent a potential “muscle full” effect 
(Atherton et al. 2010a).   Therefore, in the present study it was hypothesized that 20 g of protein 
ingested every 3 h would be the optimal intervention for repeated stimulation of MPS due to provision 
of sufficient (Moore et al. 2009a), but not excessive, protein to stimulate MPS. 
3.2 Methods 
Ethical approval  
Subjects were informed of any potential risks involved in the study before providing their written 
informed consent. The study was approved by the Australian Institute of Sport Ethics Committee and 
conformed to the standards set by the latest revision of the Declaration of Helsinki. 
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Subjects  
Twenty-four young (18-35 y), healthy non-smoking males with at least two years of high-intensity 
resistance training experience (≥ 2 times • wk-1) and relative strength for leg extensions of at least 1.3 
kg • BM-1     were recruited for this study (Table 3.1). Subjects with pre-existing conditions involving 
inadequate blood clotting or use of anabolic steroids/prohibited substances were not considered for the 
study. Subjects were recruited in the Australian Capital Territory via advertising through radio, local 
gyms and social network. Allocation of experimental subjects to groups was based on body weight to 
avoid weight differences between groups. Technical error (i.e. incorrect protein administration) 
necessitated one subject be excluded from final analysis. Body composition was measured using a 
whole body scan narrowed fan-beam dual energy X-ray analysis (DXA Lunar Prodigy, GE 
Healthcare, Madison, WI) with  GE Encore 13.60 software (GE, Madison, WI). Anthropometric 
measurements and 1 repetition maximum (RM) were assessed 1-2 weeks before experimental trials.  
 
Table 3.1 Subjects characteristics. RM, repetition Maximum for leg extension exercise 
 
   Group  
    
 Bolus Intermediate Pulse 
    
N 8 7 8 
Age (y) 25 ± 5 25 ± 3 25 ± 5 
Body mass (kg) 83.6 ± 10.5 80.5 ± 11.1 82.0 ± 6.4 
Percentage Fat 16.7 ± 5.2 14.6 ± 6.9 15.1 ± 5.8 
Lean Mass (kg) 66.2±5.4 65.3±6.4 66.5±5.3 
1 RM (kg) 125 ± 9 128 ± 21 137 ± 18 
1 RM (kg)/body mass 1.51 ± 0.18 1.59 ± 0.16 1.68 ± 0.21 
       
Diet and exercise control 
 61 
 
 Subjects were each provided with individualized prepacked meals for the 72 h prior to an 
experimental trial. The standardized diets were based on achieving daily energy availability (intake 
minus energy cost of exercise) of 45 kcal·kg
-1
 fat free mass (FFM) (Loucks et al. 2011), and provided 
a daily intake of 1.5 g protein·kg
-1
 body mass (BM) and 4 g CHO·kg
-1
 BM with the remaining energy 
coming from fat. The macronutrient composition was based on current guidelines for sports nutrition 
(IOC,2011). No exercise was allowed during the 48 h period prior to a trial, but subjects were allowed 
to undertake their habitual training session during the first day of the dietary standardization, with an 
appropriate snack being provided in their pre-packaged meals to account for the energy cost of the 
session. Subjects were instructed to refrain from any alcohol or caffeine consumption 48 h prior to a 
trial and to consume the last meal of their diets prior to 2100 h the night before a trial.  A food and 
exercise checklist was completed by each subject to note the compliance to these instructions. No 
significant deviation from the standardized diet was reported by any individual. 
Experimental Trials 
Subjects were matched for BM before being randomly assigned to one of three different experimental 
groups using a parallel group design. An overview of the experimental procedure is shown in Figure 
3.1. Subjects reported to the laboratory at ~0700 h after a 10-12 h overnight fast and a Teflon catheter 
was inserted in the antecubital vein of each arm for blood sampling and tracer infusion. A primed, 
continuous (0.05 μmol·kg-1·min-1; 2 μmol·kg-1 prime) infusion of L-[ring-13C6] phenylalanine 
(Cambridge Isotopes Laboratories, Woburn, MA, USA) commenced immediately after the first 
(baseline) blood sample was drawn. After a resting period of 2 h, the first muscle biopsy was taken 
and subjects undertook the resistance exercise bout (described subsequently). After  exercise  and 
during the following 12 h recovery period, subjects consumed 80 g of a commercially available whey 
protein isolate (ISO8 WPI; 82.9 g protein, 2.1 g fat, 3.4 g carbohydrates per 100 g; Musashi, 
Australia), enriched with 5% L-[ring-
13
C6] phenylalanine, and  mixed with water to a total volume of 
1 L. Drinks were consumed within the 12 h period after the resistance exercise bout according to the 
following schedule: pulsed feeding consisting of 8×10 g in 125 mL every 1.5 h (PULSE, n=8);  
intermediate feeding consisting of 4×20 g in 250 mL every 3 h (INT, n=7); or bolus feeding 
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consisting of 2×40 g in 500 mL every 6 h (BOLUS, n=8). Water was provided ad libitum with 30 min 
restrictions before and after each protein drink to avoid any potential influence on gastric emptying. 
 
 
Figure 3.1 Schematic representation of the experimental protocol. Negative time points indicate 
before exercise, positive time points indicate after exercise. REX, Resistance Exercise. 
 
Biological Samples 
Blood samples (4 mL) were taken before the exercise bout and at repeated time-points throughout 
recovery (Figure 3.1). Muscle biopsy samples were taken from the vastus lateralis using 5 mm 
Bergström needles adapted for manual suction immediately before exercise and at 1, 4, 6, 7 and 12 h 
post-exercise. The initial three biopsies were taken from a randomly selected leg and the final three 
biopsies were taken from the contralateral leg. Distance between sampling points was ~0.5 cm and 
biopsies were taken from distal to proximal. Muscle was cleaned with saline to remove excess blood 
and immediately frozen in liquid N2. Muscle and plasma samples were stored at -80 °C until 
subsequent analysis.   
Exercise 
Bilateral leg extension 1 RM strength test was completed by each subject a minimum of one week 
prior to the experimental protocol using a plate loaded machine. After a warm up of 2 sets of 5 
moderate intensity repetitions the 1 RM was determined as the highest successfully lifted weight 
during a maximum of 6 attempts. On the day of a trial subjects completed two warm up sets of 5 
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repetitions at ~50 and ~60% 1 RM with 2 min rest between sets. The resistance exercise training bout 
incorporated 4 sets of 10 repetitions at ~80% 1 RM with 3 min rest between sets. Exercise range of 
motion was ~85°, with leg extension endpoint set at ~5° from full extension. The exercise bout 
volume and intensity were based on those used in previous studies showing significant increases in 
skeletal muscle protein synthesis (Borsheim et al. 2002; Tipton et al. 2001). 
Analytical Procedures 
Insulin and Amino Acid concentration 
Plasma insulin concentration was measured using an automated enzyme amplified 
chemiluminescence Immulite® 1000 system (Siemens diagnostics, Australia) according to 
manufacturer’s guidelines. Plasma AA were analyzed by high performance liquid chromatography to 
determine amino acid concentrations as described previously (West et al. 2011; Wilkinson et al. 
2007). Estimates of the precision of the method were determined by assessing the repeatability of 
standards (1.5, 2.5, 3.5, 5, 10 µl) injected to generate a standard curve. Coefficients of variation for 
the volumes listed above were 5 to 15%. 
Western Blot   
Muscle samples were homogenized in buffer containing 50 mM TrisHCL, pH 7.5, 1 mM EDTA, 1 
mM EGTA, 10% glycerol, 1% Triton X-100, 50mMNaF, 5mMNa pyrophosphate, 1mM DTT, 10  
g/ml trypsin inhibitor, 2 g/ml aprotinin, 1 mM benzamidine, and 1 mM PMSF. After determination of 
protein concentration (Pierce, Rockford, IL), lysate was resuspended in Laemmli sample buffer, 
separated by SDS-PAGE, and transferred to polyvinylidine fluoride membranes blocked with 5% 
nonfat milk, washed with TBST (10 mM TrisHCl, 100 mM NaCl, 0.02% Tween 20) and incubated 
with primary antibody (1:1,000) overnight at 4°C. Membranes were incubated with secondary 
antibody (1:2,000), and proteins were detected via chemiluminescence (Amersham Biosciences, 
Buckinghamshire, UK; Pierce Biotechnology, Rockford, IL) and quantified by densitometry. Amount 
of protein loaded in each well was 50μg. Polyclonal anti-phospho mammalian target of rapamycin 
(mTOR) Ser2448 (#2971), monoclonal anti-phospho-Akt Ser473 (#9271), tuberin sclerosis complex-2 
(TSC2) Thr1462 (#3617), ribosomal protein S6 Ser 235/6 (#4856), 4E-BP1 Thr 37/46 (#2855), eEF2 
Thr56 (#2331), and anti-α-tubulin control protein (#3873) were purchased from Cell Signaling 
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Technology (Danvers, MA). Polyclonal anti-phospho- PRAS40 Thr246 (#07-888), p70S6K Thr 389 
(#PK1015) were from Millipore (Temecula, CA). 
Fractional Synthetic Rate 
Pre-infusion plasma sample proteins as first measurement time-point (Burd et al. 2012b), were 
extracted in acetonitrile. Muscle tissue was processed as previously described (Moore et al. 2009b).  
Calculations 
The fractional synthetic rate of myofibrillar proteins was calculated using the standard precursor–
product method: 
FSR (%h
−1
) = [Ep2 - Ep1]/Eic × 1/t × 100 
 
Where Ep2 - Ep1 represents the change in bound protein enrichment between two biopsy 
samples; Eic is the average enrichment of intracellular phenylalanine between the two biopsy samples; 
and t is the time between biopsies. The utilization of ‘tracer-naive’ subjects allowed us to use the pre-
infusion blood sample (i.e. mixed plasma protein fraction) as the baseline enrichment (Ep1) for the 
calculation of resting MPS (Burd et al. 2010a). All measurements of enrichment, whether made using 
GC-MS or GC-C-IRMS were validated using external standard curves with standards or known 
composition. Plasma free, muscle intracellular, and protein-bound enrichments fell within the linear 
range and coefficients of variability on repeat measurements never exceeded 5-6%.   
RNA extraction, reverse transcription and RT-PCR  
Skeletal muscle (~20 mg) tissue RNA extraction, reverse transcription and real-time Polymerase 
Chain Reaction (RT-PCR) was performed as previously described (Camera et al. 2012; West et al. 
2012). Taqman-FAM-labelled primer/probes for Atrogin-1 (Hs01041408_m1*), MuRF-1 
(Hs00822397_m1*), SLC3A8 (Hs00255854_m1*), and BCAT2 (Hs01553550_m1*) primers 
(Applied Biosystems, Carlsbad, CA) were used. Glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH, HS99999905_m1*) was used as the housekeeping gene.  The relative amounts of mRNAs 
were calculated using the relative quantification (∆∆CT) method (Livak and Schmittgen 2001).   
Analysis of mRNA was restricted to 1 h, 7 h and 12 h post-exercise due to limited muscle sample at 
various time points. 
 65 
 
Statistical analysis  
Data were analyzed using two way analysis of variance (ANOVA) with Student-Newman-Keuls post 
hoc analysis (SigmaStat for Windows; Version 3.10). Data for western blotting were log-transformed 
prior to analysis. All data are presented as mean ± standard deviation (SD) and the level of statistical 
significance was set at P<0.05. 
 
3.3 Results 
Plasma insulin concentration 
There was a time × group interaction for plasma insulin concentration (P<0.001). Plasma insulin 
concentration was increased above resting levels only in BOLUS, peaking 40 min after exercise 
(Figure 3.2). Plasma insulin concentration in BOLUS was also increased above rest at 20 min, 40 min, 
1 h, 1 h 30 min, (~3-8 fold P<0.05) and 6 h 40 min, 7 h and 7 h 30 min (~2-4 fold; P<0.05) post 
exercise after the first and second drink respectively.  BOLUS was greater than INT and PULSE 
conditions at the corresponding time points (~2-4 fold; P<0.05).  
 
Figure 3.2 Plasma Insulin concentration following a bout of leg extension resistance exercise (4 sets 
× 10 repetitions at 80% one repetition maximum) and post-exercise ingestion of 80 g whey protein 
consumed using a Bolus (2 × 40 g every 6 h), Intermediate (4 × 20 g every 3 h) or Pulse (8 × 10 g 
every 1.5 h) ingestion protocol during a 12 h recovery period. -0 and +0 h are pre and post exercise 
respectively. Data were analyzed by using a 2 way ANOVA with Student-Newman-Keuls post hoc 
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analysis. Values are mean ± SD. Different vs § all other time points within treatment; a, rest; †, 
Intermediate and *, Pulse at equivalent time point (P<0.05) 
 
Plasma Amino acids  
There was a time × group interaction (P<0.001) for plasma EAA, BCAA and leucine concentrations. 
There were robust increases in AA concentration during the early (1-6 h) recovery period following 
BOLUS compared to more moderate changes for INT and PULSE (Figure 3.3). EAA concentration 
increased above resting levels after feeding in BOLUS peaking 40 min post exercise (135%; 
P<0.001).  BCAA and leucine concentrations were different from rest 40 min after ingestion of 
BOLUS (37 and 57% respectively; P<0.05) and remained elevated 3.5 h post exercise. After the 
initial INT feeding there was a trend towards difference from rest for leucine (P=0.06) but not for 
BCAA or EAA. Changes in AA concentration with PULSE did not increase above resting values 
during the 1-6 h recovery period.   
During the late recovery period (6-12 h) the different AA sub-fractions increased above 
resting levels in response to all feeding protocols. However, peak EAA, BCAA and leucine 
concentrations were higher for BOLUS (87-205%; P<0.001), compared with INT (110-39%; P<0.04) 
and PULSE (67-174%; P<0.004). Notably, PULSE sustained the increase in AA concentration above 
resting values throughout the 6-12 h recovery period (64-83%; P<0.03) and remained above resting 
values at 12 h (42-83%; P<0.005). The concentration of each AA sub-fraction with BOLUS remained 
elevated at 9 h (52-87%; P<0.001) and BOLUS and INT returned to resting values at 12 h and were 
lower compared to PULSE at the end of recovery for EAA (19-50%; P<0.05). The increase in AA 
concentration with INT was restricted to the 6-7 h period (i.e. 6 h 40 min) and was lower in INT than 
PULSE and BOLUS at the equivalent time point (21-41%; P<0.04).   
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Figure 3.3  Plasma essential amino acids (EAA; A); Branched-chain amino acids (BCAA; B); 
Leucine (C) concentration  following a bout of leg extension resistance exercise (4 sets × 10 
repetitions at 80% one repetition maximum) and post-exercise ingestion of 80 g whey protein 
consumed using a Bolus (2 × 40 g every 6 h), Intermediate (4 × 20 g every 3 h) or Pulse (8 × 10 g 
every 1.5 h) ingestion protocol during a 12 h recovery period. Data were analyzed by using a 2 way 
ANOVA with Student-Newman-Keuls post hoc analysis.  Values are mean ± SD. Different vs a, rest; 
*, Pulse, †, Intermediate and ‡, Bolus at equivalent time point (P <0.05). 
 
Intracellular and Plasma Tracer Enrichments. Intracellular free phenylalanine enrichments showed a 
stable precursor pool throughout the 14 h infusion in all groups (Figure 3.4A). Linear regression line 
slope of plasma enrichments were not significantly different from zero in BOLUS, INT and PULSE 
groups (P = 0.96, 0.98, 0.99 respectively; Figure 3.4B). 
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Figure 3.4 Intracellular (A) and venous plasma (B) L-[ring-13C6] phenylalanine enrichment for each 
treatment group during experimental trials. Values are mean ± SD. TTR, Tracer to Tracee Ratio. 
 
Myofibrillar Fractional Synthetic Rate 
Each ingestion protocol resulted in increased myofibrillar FSR above resting values throughout 1-12 h 
of recovery (88–148%; P<0.02; Figure 3.5B) with values of 0.06, 0.079 and 0.053 %·h-1 for PULSE, 
INT and BOLUS respectively.  There were corresponding increases in FSR during the early 1-4 h 
recovery period regardless of timing or quantity of protein ingestion (Figure 3.5A). Thereafter, INT 
generated a superior FSR compared to PULSE and BOLUS during the 4-6 and 6-12 h periods (47-
78% and 34-42% respectively; P<0.02). Consequently, INT elicited a greater rate of myofibrillar FSR 
during the entire 1-12 h period compared to both PULSE and BOLUS (31 and 48% difference 
respectively; P<0.02). 
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Figure 3.5 Myofibrillar Fractional Synthetic Rate (FSR) between time points (A) and mean FSR 
throughout 1-12 h (B) following a bout of leg extension resistance exercise (4 sets × 10 repetitions at 
80% one repetition maximum) and post-exercise ingestion of 80 g whey protein consumed using a 
Bolus (2 × 40 g every 6 h), Intermediate (4 × 20 g every 3 h) or Pulse (8 × 10 g every 1.5 h) ingestion 
protocol during a 12 h recovery period. Data were analyzed by using a 2 way ANOVA with Student-
Newman-Keuls post hoc analysis. Values are mean ± SD expressed as %·h
-1
; Different vs a, Rest; b, 
1-4 h; ‡, Bolus and *, Pulse at equivalent time point (P<0.05). 
 
Signalling responses 
Akt/TSC 2. Akt Ser473 phosphorylation during recovery from exercise increased above rest in 
BOLUS at 1 h (~4 fold) and was higher than all other time points (P<0.05; Figure 3.6A).  
Phosphorylation of Akt at 1 h was also greater in BOLUS compared to INT and PULSE (~2 fold 
difference; P<0.03) whereas at 7 h it was higher in both BOLUS and INT compared to PULSE (~3 
and ~2 fold difference respectively; P<0.02). Similar to Akt Ser473 the phosphorylation of 
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TSC2Thr1462 increased above resting values only in BOLUS at 1 and 7 h (~4 and 3 fold respectively; 
P<0.002; Figure 3.6B). At the 4 h time point until the end of the recovery (12 h) TSC2 
phosphorylation in INT was generally lower than BOLUS and PULSE (~3-2 fold; P<0.05). 
 
mTOR/PRAS40. The protein ingestion protocols generated similar increases in phosphorylation of 
mTOR Ser2448 throughout  12 h recovery (Figure 3.6C).  Generally, all time points for each group 
were higher than rest (~2 to ~6 fold, P<0.05). Peak mTOR phosphorylation occurred in BOLUS at 1 
and 7 h post-exercise (~6 and ~5 fold respectively) but was not different from INT or PULSE at the 
equivalent time point. There was a significant increase in PRAS40 Thr246 phosphorylation above 
resting values in BOLUS at 1 and 7 h (~3 fold; P<0.05) and INT at 7 h (~3 fold; P<0.05) after 
cessation of exercise but the phosphorylation state of PRAS40 Thr246 was unchanged with PULSE 
(Figure 3.6D). Phosphorylation of PRAS40 Thr246 after 1 h of recovery was higher in BOLUS 
compared with INT and PULSE (~2 and ~3 respectively, P<0.05) whereas at 7 h both BOLUS and 
INT were different from PULSE (~7 and ~6 fold respectively, P<0.001). 
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Figure 3.6 Phosphorylation of Akt Ser473 (A), TSC2 Thr1462 (B), mTOR Ser2448 (C), PRAS40 
Thr246 (D), p70 S6K Thr389 (E) and rpS6Ser 235/236 (F) following a bout of leg extension 
resistance exercise (4 sets × 10 repetitions at 80% one repetition maximum) and post-exercise 
ingestion of 80 g whey protein consumed using a Bolus (2 × 40 g every 6 h), Intermediate (4 × 20 g 
every 3 h) or Pulse (8 × 10 g every 1.5 h) ingestion protocol during a 12 h recovery period. Data were 
analyzed by using a 2 way ANOVA with Student-Newman-Keuls post hoc analysis. Values are mean 
± SD expressed as arbitrary units. Different vs §, all  time points within treatment; a, rest; b, 1h post-
exercise; d, 6h post-exercise; e, 7 h post exercise; f, 12h post exercise; *, Pulse; †, Intermediate; and 
‡, Bolus at equivalent time point (P<0.05). 
 
p70S6K/rpS6. p70S6SK Thr389 phosphorylation was elevated above resting values during the 12 h of 
recovery for all ingestion protocols (~3 to ~26 fold; P<0.02) but with different magnitudes in the 
response between interventions (Figure 3.7A). BOLUS elicited the highest phosphorylation at 1 h 
(~26 fold; P<0.001) with a second lower peak at 7 h (12 fold; P<0.001). Phosphorylation in INT 
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peaked at 1 h (12 fold; P<0.001) and 4 h (7 fold; P<0.001) but was similar throughout the remainder 
of the recovery period. Phosphorylation of p70S6K above rest in PULSE showed little variation 
between time points (3-6 fold). The p70S6SK Thr389 phosphorylation response at 1 h was higher in 
BOLUS and INT compared to PULSE (~5 and ~2 fold respectively; P<0.02) and at 7 h was higher in 
BOLUS than INT and PULSE (~2 and ~3 fold respectively; P<0.02). 
  rpS6Ser 235/236 phosphorylation was only higher than resting levels during recovery in 
BOLUS at 1 and 7 h post-exercise (12 and ~6 fold respectively; P<0.01; Figure 3.7B). 
Phosphorylation at the 1 h time point was higher in BOLUS compared to PULSE (~5 fold; P<0.03), 
and at 7 h phosphorylation was higher in BOLUS than both INT and PULSE (~3 and ~7 fold 
respectively; P<0.05). 
 
Figure 3.7 Phosphorylation of p70 S6K Thr389 (A), rpS6Ser 235/236 (B), eEF2 Thr52 (C) and 
4EBP1 Thr37/46 (D) following a bout of leg extension resistance exercise (4 sets × 10 repetitions at 
80% one repetition maximum) and post-exercise ingestion of 80 g whey protein consumed using a 
Bolus (2 × 40 g every 6 h), Intermediate (4 × 20 g every 3 h) or Pulse (8 × 10 g every 1.5 h) ingestion 
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protocol during a 12 h recovery period. Data were analyzed by using a 2 way ANOVA with Student-
Newman-Keuls post hoc analysis. Values are mean ± SD expressed as arbitrary units. Different vs §, 
all  time points within treatment; a, rest; d, 6h post-exercise; f, 12h post exercise; *, Pulse and †, 
Intermediate at equivalent time point (P<0.05). 
Representative blots for all proteins are shown in Figure 3.8. 
 
Figure 3.8 Representative images of western blots. 
 
mRNA Responses.  
The mRNA abundance of MuRF-1 increased at 1 h post exercise compared to all other time-points in 
INT and PULSE (2-3 fold compared to rest; P<0.001) but MuRF-1 mRNA did not change during the 
recovery period in BOLUS. Consequently, MuRF-1 expression was higher in INT and PULSE 
compared to BOLUS at 1 h (P<0.001; Figure 3.9A). There were no differences in the abundance of 
Atrogin-1 mRNA within or between groups during the entire recovery period (data not shown). 
SLC38A2 (SNAT2) mRNA expression was increased at 1 h post-exercise compared to all 
other time points within BOLUS (~2 fold compared to rest; P<0.05), but there was no change after 
either INT or PULSE protocols (Figure 3.9B). There were no changes in mRNA expression of BCAT 
2 during the recovery period (data not shown). 
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Figure 3.9 MuRF-1 (A) and SLC38A2 (B) mRNA expression relative to GAPDH following a bout of 
leg extension resistance exercise (4 sets × 10 repetitions at 80% one repetition maximum) and post-
exercise ingestion of 80 g whey protein consumed using a Bolus (2 × 40 g every 6 h), Intermediate (4 
× 20 g every 3 h) or Pulse (8 × 10 g every 1.5 h) ingestion protocol during a 12 h recovery period. 
Data were analyzed by using a 2 way ANOVA with Student-Newman-Keuls post hoc analysis. 
Values are mean ± SD. Different vs §, all time points within group; ¶, all time points within group and 
BOLUS at equivalent time point (P<0.05). 
 
3.4 Discussion 
This study provides novel information demonstrating that the regulation of muscle protein synthesis 
can be substantially modulated by the timing and distribution of 80 g of protein intake during 
prolonged (12 h) recovery from a single bout of resistance exercise. Specifically, it is shown for the 
first time that rates of myofibrillar protein synthesis (MPS) remain elevated above rest throughout 12 
h of recovery when a single bout of resistance exercise is followed by the partitioned ingestion of 80 g 
of high quality protein. Furthermore, it is shown that daily rates of protein synthesis were highest with 
regular (i.e. every 3 h) intake of a moderate (20 g) quantity of rapidly digested whey protein. It is also 
shown that the nutrient- and contraction- sensitive intracellular signalling network regulating 
translation for protein synthesis was stimulated in response to all feeding protocols but in a 
hierarchical manner where BOLUS was higher than INT and PULSE.  
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Previous studies examining the effects of protein availability on mixed muscle protein 
synthesis at rest have shown that despite prolonged hyperaminoacidemia, rates of muscle protein 
synthesis return to resting levels within 2 h after peak aminoacidemia (Atherton et al. 2010a; Bohe et 
al. 2001). As might be expected, the provision of exogenous protein post-exercise elevated MPS 
above basal levels regardless of the feeding pattern. The INT bound incorporation values, despite 
appearing systematically lower are not statistically different. Therefore, intracellular enrichments over 
the 12 h feeding period are not the reason for the higher FSR values in INT. Consequently, the 
superior MPS in INT was possibly due to an optimised interplay between resistance exercise, time 
between ingestion, and quantity of each (whey) protein feeding: this likely resulted in a cyclical 
plasma AA profile that might be considered ideal to stimulate MPS. Previous studies have reported 
that there appears to be a minimum threshold for elevation of blood aminoacidemia to generate 
maximal rates of muscle protein synthesis and that a sufficient quantity of rapidly digested protein is 
required to transiently induce an optimal protein synthesis response (Moore et al. 2009a; West et al. 
2011). While the temporal resolution of time-points selected for quantifying plasma amino acid 
concentrations failed to clearly show distinct amino acid profiles throughout the 12 h post-exercise 
period a hierarchical response was observed for leucine concentration early in recovery indicative of 
an initial divergence in branched-chain amino acid availability between feeding patterns (Figure 3.3). 
Thereafter, the continuous hyperaminoacidemia or lack of postprandial periods of relative 
hypoaminoacidemia over the 12 h period with PULSE feeding likely resulted in some suboptimal 
stimulation of the protein synthesis machinery similar to that observed with continuous amino acid 
infusion. In contrast, larger boluses of protein (i.e. >20g) are sufficient to maximally stimulate muscle 
protein synthesis, but represent a suboptimal ingestion pattern  due to  irreversible amino acid 
oxidation of the excess protein (Moore et al. 2009a).  Given that the fraction of protein that appears in 
the systemic circulation seems to be constant regardless of the size of the protein meal (Pennings et al. 
2012), the fate of the amino acids ingested may be in tissues other than skeletal muscle with PULSE 
and BOLUS feeding patterns. A limitation of the current study is that these results may only be valid 
for individuals of average body mass (i.e. 70-80 kg). Similar ingestion regimens should be assessed in 
other populations (e.g. obese) and represent an area for future studies.  
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The present study did not include an exercise only intervention but the additive effect of 
protein ingestion on the anabolic response following resistance exercise is well established and rates 
of MPS would be superior compared with resistance exercise in isolation regardless of the ingestion 
protocol (Biolo et al. 1995b; Biolo et al. 1997; Moore et al. 2009a). The 12 h post-exercise recovery 
was chosen for being representative of multiple daily feeding opportunities. This study was purposely 
designed to isolate the effects of protein intake and avoid interference by carbohydrate or fat 
ingestion, as protein alone has been shown to robustly stimulate muscle protein synthesis after 
exercise (Biolo et al. 1997; Burd et al. 2010a; Moore et al. 2009a; Moore et al. 2009b; Tipton et al. 
2003; Tipton et al. 1999; West et al. 2011). Considering the individuals in the present study required 
~3000 kcal/day to attain energy balance and that subjects were provided with ~320 kcal from protein 
beverages during the 12 h treatment period ensured maintenance of negative energy balance. In 
addition, the majority of studies employing protein ingestion protocols are undertaken after an 
overnight fast, yet still result in robust increases in resting and exercise-induced myofibrillar protein 
synthesis (Atherton et al. 2010a; Biolo et al. 1997; Bohe et al. 2001; Burd et al. 2010a; Burd et al. 
2011b; Moore et al. 2009a; Moore et al. 2009b; Tipton et al. 1999; West et al. 2011). Consequently, in 
conditions of energy balance a similar MPS response would be expected.  
The present data extend the findings of previous studies with the novel observation that the 
pattern of protein intake can modify the extent of muscle protein synthesis during the late (i.e. 6-12 h) 
period of recovery. In the present study, the cumulative protein intake by the 1-4 h period post-
exercise was 40 g for BOLUS and INT, and only 30 g for PULSE. Yet despite these different patterns 
of intake, it has previously been shown (Cuthbertson et al. 2005; Moore et al. 2009a; Pennings et al. 
2012) that >20 g of protein is sufficient to induce maximal rates of protein synthesis in the early 
recovery period. The divergence in the MPS response after 4 h, with superior outcomes for INT, 
suggests that the timing and distribution of protein intake becomes a critical factor for optimizing 
MPS late in recovery. The results indicate that 20 g of rapidly digested high-quality protein every 3 h 
provides both sufficient amino acids and an adequate latency period for repeated stimulation of 
muscle protein synthesis. The implication is that 40 g of protein every 6 h, which simulates a daily 
pattern of “three square meals”, or 10 g of protein every 1.5 h simulating a ‘grazing’ eating pattern, 
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are inferior in their capacity to stimulate MPS. However, it should be noted that these findings apply 
to rapidly digested whey protein and mixed meal consumption of whole foods, or a slow digested 
protein such as casein, would likely reduce the magnitude of plasma aminoacidemia and subsequent 
MPS response but intuitively the relative effect of the pattern and timing of protein ingestion would 
likely remain. Indeed, these findings indicate individuals who have the goal of maximally stimulating 
muscle anabolism may benefit from strategies that regularly isolate rapidly digested, high quality 
protein ingestion from other daily nutrient intakes. It must also be pointed out, considering the inter-
individual variability in metabolism, that the energy availability of the experimental subjects during 
the controlled diet period might have been slightly lower or higher than 45 kcal•kg-1 fat free mass 
(FFM) for some subjects and may have potential to add variability to metabolic responses.  
Regardless, we suggest that the current population recommendations for protein intake, which are 
provided as a total daily target without consideration of the pattern of protein intake, should be 
reassessed in view of the likely impact on muscle protein metabolism and, subsequently, lean body 
mass. Such a concept has been raised previously when  protein metabolism has been estimated from 
the traditional nitrogen balance techniques (Leverton and Gram 1949).  
Results from the cell signalling data provide new information regarding nutrient-exercise 
interactions regulating translation initiation events. As might be expected, as a critical node in the 
insulin signalling network (Taniguchi et al. 2006), phosphorylation of Akt Ser473 and its downstream 
targets TSC2 Thr1472 and PRAS40 Thr246 corresponded closely to changes in plasma insulin 
concentration. The mTORC1 regulates metabolic activity and is a focal point for integrating nutrient 
(i.e. amino acid) and  exercise signal transduction  (Camera et al. 2010; Dreyer et al. 2008; Dreyer et 
al. 2006; Rivas et al. 2009b; Terzis et al. 2010; Zoncu et al. 2011). Interestingly, phosphorylation of 
Ser2448 was ~2 to ~6 fold above resting values during the entire recovery period independent of the 
protein ingestion protocol. This is the first study to show prolonged (12 h), sustained increases in 
phosphorylation of mTOR Ser2448 above rest consistent with elevated muscle protein synthesis 
above rest. Similarly, p70S6K Thr389 phosphorylation increased above rest throughout the recovery 
period in all ingestion protocols, although the magnitude of the response differed and was dependent 
on the pattern of protein ingestion (BOLUS>INT>PULSE at the 1 and 7 h recovery time points). As a 
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signalling kinase proximal to translation initiation, p70S6K is promoted as a physiological marker 
closely associated with muscle protein synthesis (Baar and Esser 1999; Burd et al. 2010a; Fry et al. 
2011; Kumar et al. 2009b).  No correlation between the degree of phosphorylation of S6K and the 
myofibrillar FSR response was found (r=0.2, p=0.34). The lack of change in 4EBP1 Thr37/46 
phosphorylation following exercise and protein ingestion was unexpected but has been observed 
previously (Breen et al. 2011; Burd et al. 2012a; Coffey et al. 2011) and might be attributable to 
insufficient volume and/or intensity of exercise or possibly due to competitive interaction with 
p70S6K as a Raptor substrate (Dennis et al. 2013).  Similarly, a nutrient sensitive response for eEF2 
phosphorylation which has also been shown by others (Breen et al. 2011; Burke et al. 2012a; Moore et 
al. 2011) was not observed.  Accordingly, the results support the premise that the snapshot provided 
by quantification of mTOR-S6K phosphorylation is indicative of elevated MPS compared to baseline 
but does not accurately reflect the magnitude or duration of the MPS response.  
Modulating intake of macronutrients also generates changes in transcriptional activity of the 
muscle cell (Borgenvik et al. 2012; Drummond et al. 2010). The BOLUS condition induced an early 
post-exercise increase in mRNA expression of the amino acid transporter SLC38A2/SNAT2 while 
there was a repressed expression of MuRF-1 compared with INT and PULSE feeding protocols. The 
increase in amino acid transporter and blunting of ubiquitin ligase expression has been shown 
previously (Borgenvik et al. 2012; Drummond et al. 2010) but the physiological significance of such 
changes has yet to be clearly defined. Nonetheless, the results indicate that a large bolus feeding of 
amino acids, or possibly high plasma leucine concentrations (Churchward-Venne et al. 2012), may be 
necessary to substantially alter the transcriptional activity in muscle. However, this effect was no 
longer evident following a second bolus ingestion 6 h later and may indicate that an exercise-nutrient 
interaction is required to induce changes in transcription of specific gene targets (Drummond et al. 
2011; Drummond et al. 2010). Nonetheless, the possibility exists that a large bolus of protein is 
advantageous for enhancing AA transporter expression and/or suppressing catabolic activity 
compared with moderate-small quantities of protein intake during the early post-exercise recovery 
period. 
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In conclusion, the results from the current study provide new information demonstrating that 
the timing and distribution of protein ingestion is a key factor in maximally stimulating rates of MPS 
throughout an entire day. During the 12 h recovery period after a single bout of resistance exercise 20 
g of whey protein ingested every 3 h was the optimal feeding pattern for promoting enhanced rates of 
MPS in the present study. These results highlight the importance of the interplay between timing and 
quantity of protein ingestion on MPS over the course of each day and represent an important dietary 
message that merits consideration for population recommendations for daily protein intake.  The 
chronic effects and practicalities of incorporating such an ingestion strategy within the total daily 
eating plan including whole foods represent areas for future study. In the meantime, this study 
emphasizes that the timing of protein intake is a separate variable and a crucial factor in the 
development of optimal nutritional strategies to maintain and/or enhance peak muscle mass in 
humans. 
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Chapter Four 
 
 
 
Reduced resting skeletal muscle protein synthesis is rescued by 
resistance exercise and protein ingestion following short-term 
energy deficit.  
 
 
 
Adapted from: José L. Areta, Louise M. Burke, Donny M. Camera, Daniel W.D. West, 
Siobhan Crawshay, Daniel R Moore, Trent Stellingwerff, Stuart M. Phillips, John A. Hawley 
and Vernon G. Coffey (2013). To be submitted to the American Journal of Clinical Nutrition 
(intellectual property release agreement in process) 
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4.1 Introduction 
Energy deficit (ED) can be achieved through reduced energy intake and/or increase energy 
expenditure and subsequently leads to loss of fat mass (FM). A reduction in FM is a goal for 
improved health (Hansen et al. 2007; Mettler et al. 2010); however, when achieved by energy 
restriction alone, typically results in the concomitant weight loss comprised of ~25% fat free mass 
FFM (Weinheimer et al. 2010), of which skeletal muscle is the main component (Müller et al. 2002; 
Parr et al. 2013). Given that the quality and quantity of skeletal muscle is a major determinant of 
whole body metabolic rate and functional capacity throughout the life span (Karagounis and Hawley 
2010), nutritional and exercise strategies to prevent or minimize loss of FFM while losing fat mass are 
crucial. 
Pasiakos and colleagues (Pasiakos et al. 2010) reported a 19% reduction in basal rates of 
mixed muscle protein synthesis in young healthy males and females after 10 days of  ED (~500 
kcal/day). In contrast, a recent study from the same group (Pasiakos et al. 2013) reported no decrease 
in rates of resting muscle protein synthesis after 30 day of moderate ED. If a potential decrease in 
basal rates of muscle protein synthesis were not accompanied by a concomitant reduction in muscle 
protein breakdown, then ED would presumably result in a marked loss of skeletal muscle protein. 
Indeed, prolonged ED-induced body weight loss can be comprised of up to 60% fat free mass 
(Pasiakos et al. 2013). In contrast, exercise has been shown to attenuate the loss of lean body tissue 
that can occur with periods of ED (Stiegler and Cunliffe 2006). However, it is currently unknown if 
the anabolic effects of resistance exercise are attenuated during periods of ED. 
Provision of dietary amino acids increases skeletal muscle protein synthesis, an effect that is 
enhanced by prior resistance exercise (Biolo et al. 1997; Moore et al. 2009b). Whether skeletal muscle 
exhibits ‘anabolic resistance’ to exercise and protein ingestion following short-term ED has been 
examined in only a single study (Pasiakos et al. 2013) but it in that study mixed muscle and not 
myofibrillar protein synthesis (MPS; i.e., the contractile protein fraction of muscle) was measured, 
there was no examination of the impact of exercise, and the subjects were mostly male. Hence, the 
primary aim of the current study was to determine the effects of ED in combination with resistance 
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exercise two levels of protein intake on skeletal muscle translation initiation signaling, mRNA 
expression, and rates of MPS. In addition, as reflected by the ‘female athlete triad’ women may be 
more susceptible to dysregulation of the endocrinological milieu during periods of ED (Loucks et al. 
2011), a second aim was to identify potential sex-based differences in skeletal muscle anabolism in 
response to ED. The general hypothesis was that short-term ED would reduce basal rates of muscle 
protein synthesis at rest but this impairment would be overcome by a combination of resistance 
exercise and protein feeding. In addition, the effect two levels of post-exercise protein intake as higher 
protein intake may be more efficacious in ED was assessed. 
 
4.2 Methods 
Ethical approval 
Subjects were informed of any potential risks involved in the study before providing their written 
informed consent. The study was approved by the Australian Institute of Sport Ethics Committee and 
conformed to the standards set by the latest revision of the Declaration of Helsinki. 
Subjects  
Sixteen (8 females, 8 males) young (18-40 y), healthy non-smoking males with at least two years of 
high-intensity resistance training experience (≥ 2 times • wk-1) commenced the study but one female 
participant withdrew from the trial (Table 4.1). Subjects with pre-existing conditions involving 
inadequate blood clotting or current or prior use of anabolic steroids or other prohibited substances 
were not considered for the study. Subjects were recruited in the Australia Capital Territory via 
advertising the research study through radio, local gyms and social network. Subjects with pre-
existing conditions involving inadequate blood clotting or current or prior use of anabolic steroids or 
other prohibited substances were not considered for the study. Body composition was measured 1-2 
weeks before the first experimental trial using a whole body scan narrowed fan-beam dual energy X-
ray analysis (DXA Lunar Prodigy, GE Healthcare, Madison, WI) with  GE Encore 13.60 software 
(GE, Madison, WI).  
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Experimental design  
The study employed a within subject design, with subjects completing four experimental 
interventions: energy balance (EB) at rest; energy deficit (ED) at rest; and then ED with exercise both 
with and without protein feeding. The effect of ED on MPS at rest when EB is re-established is 
currently unknown. In the present study trials were performed in a randomized order with the 
exception of the EB trial, which was always undertaken first, to avoid any potential dysregulation in 
an EB trial induced by prior ED (Figure 4.1).  
Table 4.1 Subjects characteristics. 1RM, 1 Repetition Maximum; BM, Body Mass; BMI, Body Mass 
Index; FFM, Fat Free Mass. Data were analyzed by using multiple T-tests. 1 RM values are for 45ᵒ 
leg-press. Values are mean ± SD.* different between sexes (P < 0.05). 
 
      
  Males Females 
N 8 7 
Age (Years) 27 ± 5 28 ± 4 
Body mass (kg) * 82.7 ± 6.6 70.3 ± 7 
Fat (% BM) * 14.9 ± 3.5 28.7 ± 5.3 
Lean Mass (kg) * 67.2 ± 6.2 48.1 ± 4.3 
Height (cm) * 180 ± 5 164 ± 7 
BMI 25.3 ± 1 26 ± 4 
1 RM (kg) * 300 ± 70 200 ± 38 
1 RM (kg)/BM (kg) * 3.6 ± 0.8 2.8 ± 0.3 
 1 RM (kg)/ FFM (kg)    4.5 ± 0.9 4.2 ± 0.7 
 
 
Dietary intervention 
Subjects were each provided with individualized pre-packaged meals for 5 days before each 
experimental trial. Before the resting EB trial, subjects were provided with meals equivalent to an 
energy availability (EA) of 45 kcal∙kg-1 FFM ∙ day-1, where EA is defined as energy intake minus the 
energy cost of exercise. For all ED trials, diets consisted of an energy availability of 30 kcal∙kg-1 FFM 
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∙day-1. Between days 1-3 of the dietary control period subjects were permitted to exercise and the diet 
increased caloric content to account for the energy expenditure of the exercise sessions and thus 
restore EA to the set level. Energy expenditure of exercise was estimated by assessing training type. 
Energy expended per unit of time was determined using caloric energy expenditure charts for 
different activities developed at the Australian Institute of Sports (Burke L.M., unpublished). The total 
protein content was 1.4 g∙kg-1 BM∙day-1 for both dietary treatments based on the suggested 
requirements for resistance trained individuals under EB and ED (Phillips 2006). No alcohol was 
consumed by the subjects during the 5 day dietary control period, and they refrained from caffeine 
intake 24 h before each trial day. Between experimental trials, there was a 9 day ‘washout’ period 
during which subjects continued with their normal exercise and dietary habits. 
 
 
 
Figure 4.1 Schematic of the experimental design. The resting energy balance (EB) trial was 
preceded by 5 days of controlled diet providing 45 kcal•kg -1 FFM • day. The resting/exercise 
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in energy deficit (ED) trials were preceded by 5 days of controlled diet providing 30 kcal•kg-1 
FFM • day. Solid arrow, muscle biopsy sample; *, blood sample; REX, resistance exercise; 0 
g, 15 g and 30 g represent the respective placebo or whey protein drinks (500 mL). Dashed 
time-line represent trials undertaken a single time by each subject. Times in parentheses are 
for ED trials involving exercise and protein intake. 
 
Experimental Trials 
After five days of dietary control, subjects reported to the laboratory between 0700 and 0800 h after a 
~10 h overnight fast and a Teflon catheter was inserted in the antecubital vein of each arm for blood 
sampling and tracer infusion. A first (baseline) blood sample was drawn for the resting EB trial (or 
muscle biopsy from the vastus lateralis was obtained for the ED trials) immediately before a primed, 
continuous (0.05 μmoL·kg-1·min-1; 2 μmol·kg-1 prime) infusion of L-[ring-13C6]phenylalanine 
(Cambridge Isotopes Laboratories, Woburn, MA, USA) commenced.  
After a 3 h resting period, a muscle biopsy was obtained. For non-tracer naïve subjects is not 
possible to measure the background enrichment of the tracer used from blood protein. In this case the 
baseline enrichment must be measured directly from skeletal muscle. Thus, for specific subjects a 
muscle biopsy was taken before the commencement of the infusion in EB.  
The ED trials were undertaken after the resting EB trial with the protein/placebo ingestion 
randomized and counterbalanced. Drinks contained 15 g or 30 g of protein (ISO8 WPI; 86.8 g protein, 
1.5 g fat, 3.1 g carbohydrates per 100 g; Musashi, Australia) or no protein given in the form of a 
flavour and volume matched placebo drink. The placebo drink was taste-matched to the protein drinks 
by adding artificial vanilla flavour and non-caloric sweetener to water. Pilot testing indicated that 
individuals were not able to identify the placebo from the protein drinks.  Each protein drink was 
enriched with 5% L-[ring-
13
C6] phenylalanine and mixed with water to a total volume of 500 mL. The 
first ED trial for each subject was divided in two periods. The first (pre-exercise) period of the trial 
determined resting ED and was identical to the EB trial with the exception of an initial muscle biopsy. 
In the second period, subjects undertook a bout of resistance exercise (REX; described subsequently) 
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with muscle biopsies obtained 1 h and 4 h post-exercise. Drinks were ingested immediately following 
cessation of an exercise bout. The remaining ED trials were identical but primed constant infusion of 
tracer commenced prior to exercise.  
Exercise 
A one repetition maximum (1 RM) inclined (45º) leg press (GLPH1100, Body-Solid, Forest Park IL) 
test was completed by each subject a minimum of one week prior to the experimental trials. After a 
warm up of 2 sets of 5 moderate intensity repetitions the 1 RM was determined as the highest 
successfully lifted weight during a maximum of 6 attempts.  On the day of an ED experimental trial 
subjects completed two warm up sets of 5 repetitions at ~50 and ~60% 1 RM with 2 min rest between 
sets. The resistance exercise training bout incorporated 6 sets of 8 repetitions at ~80% 1 RM with 3 
min rest between sets. Exercise range of motion was ~85° for the knee joint, with leg extension 
endpoint set at ~5° from full extension. The exercise volume and intensity were based on previous 
studies showing exercise-induced increases in skeletal muscle protein synthesis (Kumar et al. 2009a). 
 
 Biological Samples 
Blood samples (4 mL) were taken at rest, before the exercise bout and at repeated time-points 
throughout recovery (Figure 4.1). Muscle biopsy samples were taken from different incisions, 
separated by ~1 cm using 5 mm Bergström needles adapted for manual suction. Muscle was cleaned 
with saline solution to remove excess blood and immediately frozen in liquid N2. Muscle and plasma 
samples were stored at -80 °C until subsequent analysis. 
 
Analytical Procedures 
 
Insulin and Amino Acid concentration 
Plasma insulin concentration was measured using an automated enzyme amplified 
chemiluminescence Immulite® 1000 system (Siemens diagnostics, Australia) according to 
manufacturer’s guidelines. Plasma amino acids (AA) were analyzed by gas chromatography-mass 
spectrometry using EZ:faast kit (Phenomenex, USA)  
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Western Blot 
Intracellular signalling proteins were extracted, isolated and quantified as previously described 
(Coffey et al. 2011). Amount of protein loaded in each well was 40 μg. Polyclonal anti-phospho 
mammalian target of rapamycin (mTOR) Ser2448 (#2971), monoclonal anti-phospho-Akt Ser473 
(#9271), ribosomal protein S6 Ser 235/6 (#4856), 4E-BP1 Thr37/46 (# 2855), eEF2 Thr56 (# 2331), 
AMPK Thr172 (#2535) and anti-α-tubulin control protein (#3873) were purchased from Cell 
Signaling Technology (Danvers, MA). Polyclonal anti-phospho- p70S6K Thr 389 (#PK1015) was 
from Millipore (Temecula, CA). 
Fractional Synthetic Rate 
Pre-infusion plasma sample proteins, extracted by acetonitrile, were used for the baseline enrichment 
values in tracer naïve subjects (Burd et al. 2012b). For non-tracer naïve subjects (n=3, males) a pre-
infusion muscle biopsy was used for baseline enrichment. Muscle tissue was processed as previously 
described (Moore et al. 2009b).  
 
 
Calculations 
The fractional synthetic rate of myofibrillar proteins was calculated using the standard precursor–
product method: 
FSR (%∙h−1) = [Ep2 - Ep1]/Eic × 1/t × 100 
Where Ep2 - Ep1 represents the change in bound protein enrichment between two biopsy samples; Eic is 
the average enrichment of intracellular phenylalanine between the two biopsy samples; and t is the 
time between biopsies. The utilization of ‘tracer-naive’ subjects (n=12) allowed us to use the pre-
infusion blood sample (i.e. mixed plasma protein fraction) as the baseline enrichment (Ep1) for the 
calculation of resting MPS (Burd et al. 2010a). 
 
RNA extraction, reverse transcription and RT-PCR  
Skeletal muscle tissue (~20 mg) was used to isolate RNA using a modification of the acid 
guanidinium thiocyanate–phenol–chloroform extraction, as previously described (Coffey et al. 2007). 
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Reverse transcription and real-time Polymerase Chain Reaction (RT-PCR) was performed as 
previously described (Camera et al. 2012; West et al. 2012). Taqman-FAM-labelled primer/probes for 
Atrogin-1 (Hs01041408_m1*), MuRF-1 (Hs00822397_m1*), SLC38A2 (Hs00255854_m1*), and 
SLC7A5 (Hs00185826_m1) primers (Applied Biosystems, Carlsbad, CA) were used. 
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH, HS99999905_m1*) was used as the 
housekeeping gene.  The relative amounts of mRNAs were calculated using the relative quantification 
(∆∆CT) method (Livak and Schmittgen 2001).    
Statistical analysis. 
Data were analyzed using two way repeated measures analysis of variance (ANOVA) with Student-
Newman-Keuls post hoc analysis  (gender × time) for cell signaling, RT-PCR and myofibrillar FSR 
(SigmaStat for Windows; Version 3.10). There were no differences between sexes and data were 
subsequently combined for further analysis using one way repeated measures ANOVA with Student-
Newman-Keuls post hoc test. Data for plasma insulin and amino acids concentration were analyzed 
using two way repeated measures ANOVA with Student-Newman-Keuls post hoc test where resting 
energy balance and energy deficit trials were independently analyzed from the exercise trials. Data for 
Western blotting were log-transformed prior to analysis. All data are presented as mean ± standard 
deviation (SD) and the level of statistical significance was set at P < 0.05. 
 
4.3 Results 
 
Energy intake 
The range of energy availability for the subjects was 1690-2200 kcal • day-1 in the male and 1210-
1640 kcal • day-1 in the female subjects. 
Plasma insulin concentration  
There were no differences in plasma insulin concentration during the resting EB and ED trials. There 
was a time × group interaction for plasma insulin concentration (P<0.001) after exercise and protein 
feeding (Figure 4.2).  
 89 
 
 
 
 
Figure 4.2 Plasma Insulin concentration after 5 days of energy deficit (30 kcal • kg -1 FFM • day )  
following a bout of leg press (6 sets × 8 repetitions at 80% one repetition maximum) and post-exercise 
ingestion of a placebo (PL) or 15 or 30g of whey protein drinks. Data were analyzed by two way 
repeated measures ANOVA with Student-Newman-Keuls post hoc analysis. Values are mean ± SD. 
Different vs a, rest within treatment; *, PL , †, 15g; §, 30 g at equivalent time point (P<0.05). 
 
Amino acid concentration 
There were no differences in resting essential amino acids (EAA), branched chain amino acids 
(BCAA) or leucine plasma resting concentrations during the EB and ED trials. Plasma concentrations 
of EAA, BCAA and leucine increased above pre-exercise values between 20-120 min post exercise 
(Figure 4.3) for both the 15 and 30 g treatments. The 30 g protein feeding protocol resulted in higher 
aminoacidemia at 20 min post exercise (1.4 fold; P<0.004) compared with 40 min post exercise 
following 15 g protein ingestion (1.7 fold; P<0.001). Plasma concentration peaked 40-60 min post 
exercise (1.8-1.9 fold; P< 0.001) and remained above pre exercise values until 2 h post exercise (1.6-
1.9 fold; P<0.02) in both the 15 g and 30 g treatments. Plasma EAA concentration increased in 30 g 
compared to 15 g between 20 min and 1 h post exercise (1.2-1.3 fold; P<0.03 Figure 4.3 A). Plasma 
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BCAA and leucine concentration followed a similar pattern but differences between 15 and 30 g 
remained until 2 h post-exercise (1.2-1.8 fold P<0.02; Figures 4.3 B & C). 
 
Muscle myofibrillar fractional synthetic rate  
Resting post-absorptive MPS after ED was lower compared to EB (0.019 vs 0.026 %∙h-1, P<0.001; 
Figure 4.4). Resistance exercise in ED returned MPS to values comparable to resting EB in the acute 
post exercise recovery period. Resistance exercise followed by 15 g and 30 g protein ingestion 
increased post-exercise MPS ~16% and ~34% above resting EB, respectively  (0.030 and 0.038 %∙h 
respectively; P < 0.02). The 30 g protein treatment also increased MPS above 15 g by ~14% 
(P<0.003). There were no differences between males and females in any of the treatments. Linear 
regression analysis revealed a positive correlation between the quantity of protein ingested per kg of 
BM or FFM and MPS (r
2 
=0.43 and 0.42 respectively, P<0.001, Figure 4.5). 
Intracellular L-[ring-
13
C6] phenylalanine enrichments are presented in Figure 4.6. 
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Figure 4.3 Plasma essential amino acids (EAA; A), branched-chain amino acids (BCAA; B), and 
leucine (C) concentration after 5 days of energy deficit (30 kcal • kg -1 FFM • day)  and following a 
bout of leg press (6 sets × 8 repetitions at 80% one repetition maximum) and post-exercise ingestion 
of a placebo (PL), 15 or 30 g of whey protein drinks. Data were analyzed by using two way repeated 
measures ANOVA with Student-Newman-Keuls post hoc analysis. Values are mean ± SD. Different 
vs. a, rest within treatment; †, 15 g; §, 30 g at equivalent time point (P<0.05). 
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Figure 4.4 Myofibrillar fractional synthetic rate (FSR) at rest after 5 days of energy balance (45 kcal • 
kg 
-1
 FFM • day; EB), after 5 days of energy deficit (30 kcal • kg -1 FFM • day; ED) and following a 
bout of leg press (6 sets × 8 repetitions at 80% one repetition maximum) and post-exercise ingestion 
of a placebo (PL), 15 or 30 g of whey protein drinks. Data were analyzed by using repeated measures 
ANOVA with Student-Newman-Keuls post hoc analysis. Values are mean ± SD. Different vs. a, EB; 
b, ED; c, PL; d, 15 g (P<0.02). 
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Figure 4.5 Myofibrillar fractional synthetic rate (FSR) after 5 days of energy deficit (30 kcal • kg -1 
FFM • day) following bout of leg press (6 sets × 8 repetitions at 80% one repetition maximum) plotted 
against post exercise protein intake in grams of protein per kg of body mass (BM; A) and fat free 
mass (FFM; B). Data were analyzed using linear regression.  
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Figure 4.6 Skeletal muscle intracellular L-[ring-
13
C6] phenylalanine enrichment for each treatment 
group during experimental trials. Slopes were not different from zero in any group.  Values are mean 
± SD. TTR, Tracer to Tracee Ratio. 
 
Cell signaling  
There were no differences in phosphorylation status between resting EB and ED for any of the 
proteins quantified. Akt Ser473 phosphorylation was higher than resting ED in all treatments 1 h post 
exercise (1.8-3.2 fold; P<0.05; Figure 4.7A). Protein intake increased Akt phosphorylation above 
resting EB to a similar extent 1 h post exercise regardless of protein quantity (15 g ~2.1 fold, 30 g 
~2.4 fold;  P<0.02). There were similar effects on mTOR Ser2448 and S6K Thr 389 phosphorylation. 
Protein intake increased mTOR Ser2448 phosphorylation above resting EB levels and placebo at the 1 
h post exercise time point (~2.5 fold from resting EB, ~2 fold from PL1 h; P<0.006; Figure 4.7B). 
However, only the 30 g treatment prolonged the elevation in mTOR phosphorylation to 4 h post-
exercise (~2.1 fold; P<0.05). The p70 S6KThr 389 phosphorylation increased above resting levels 1 h 
and 4 h following resistance exercise and protein ingestion (2.6-7 fold; P < 0.05; Figure 4.7C). Peak 
phosphorylation above rest was observed with 30 g protein at 1 h post-exercise (7 fold; P<0.001) and 
was higher than 15 g protein at the equivalent time point (1.8 fold, P=0.051).  Phosphorylation of 
rpS6 Ser 236/237 above resting EB was highest 1 h after exercise with post exercise protein ingestion 
(12.5-19.2 fold; P<0.001 Figure 4.7D).  There were no differences in AMPK Thr172, 4EBP1 
Thr36/47 or eEF2 Thr56 phosphorylation at any time (data not shown). 
 
 95 
 
 
Figure 4.7 Phosphorylation of skeletal muscle Akt Ser473 (A),  mTOR Ser2448 (B),  p70 S6K 
Thr389 (C), and rpS6 Ser235/236 (D) at rest after 5 days of energy balance (45 kcal • kg -1 FFM • day; 
EB), after 5 days of energy deficit (30 kcal • kg -1 FFM • day; ED)  and following a bout of leg press 
(6 sets × 8 repetitions at 80% one repetition maximum) and post-exercise ingestion of a placebo (PL), 
15 or 30g of whey protein drinks. Data were analyzed by repeated measures ANOVA with Student-
Newman-Keuls post hoc analysis. Values are mean ± SD. Different vs. a, EB; b, ED; c, PL 1.5 h; d, 
PL 4.5 h; f, 15 g 4.5 h; h, 30 g 4.5 h (P<0.05). 
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mRNA Expression 
There were only minor changes in MuRF-1 mRNA content from resting EB but MuRF-1 was 
different from rest and select post exercise time points after 4 h post-exercise recovery in the 15 g 
protein treatment (1.85 fold; P<0.003; Figure 4.8A). Atrogin-1 mRNA content at 4 h post exercise 
was higher than resting EB and ED, 1 h recovery (1.98-2.27 fold; P<0.006; Figure 4.8B). There were 
no differences in system A amino acid transporter (SNAT2) mRNA content but in all treatments there 
was a decrease in system L amino acid transporter (LAT1) mRNA content at 1 and 4 h post-exercise 
compared to resting EB (-0.49-0.6; P<0.03). In addition, LAT1 mRNA content following resistance 
exercise with PL (4 h) and 15 g protein ingestion (1 h)  was lower compared with resting ED (0.55-
0.64; P<0.04; Figure 4.8D) . 
 
Figure 4.8 MuRF-1 (A), Atrogin-1 (B), SLC38A2/SNAT 2 (C) and SLC7A5/LAT1 (D) mRNA 
abundance at rest after 5 days of energy balance (45 kcal • kg -1 FFM • day; EB), after 5 days of 
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energy deficit (30 kcal • kg -1 FFM • day; ED)  and following a bout of leg press (6 sets × 8 repetitions 
at 80% one repetition maximum) and post-exercise ingestion of a placebo (PL), 15 or 30 g of whey 
protein drinks. Data were analyzed by repeated measures ANOVA with Student-Newman-Keuls post 
hoc analysis. Values are mean ± SD. Different vs. a, EB; b, ED; c, PL 1.5h; d, PL 4.5 h; e, 15g 1.5 g; 
g, 30 g 1.5 h (P<0.05). 
 
4.4 Discussion 
The novel findings from the present study were that five days of moderate ED (Energy availability; 30 
kcal∙kg-1 FFM∙ day-1) resulted in a 27% reduction of resting muscle protein synthesis in young, 
healthy subjects. Compared to EB, REX undertaken in a fasted, energy restricted state enhanced rates 
of muscle protein synthesis to values observed at rest during EB. However, ingestion of protein 
following REX undertaken in energy deficit elevated the anabolic (MPS and signaling) responses 
above values seen at rest during EB in a dose-dependent manner.  Finally, the amino acid transporter 
transcriptional response to resistance exercise and protein ingestion is down regulated in healthy 
individuals in ED.  
Pasiakos and colleagues have previously reported that 10 days of ED (~500 kcal • day-1) 
reduced resting rates of mixed muscle protein synthesis by ~19% (Pasiakos et al. 2010). The data 
confirm the physiological response to energy deficit in vivo skeletal muscle and provide novel data to 
show there is a similar (27 ± 12% –SD–) decrease on myofibrillar FSR after only 5 days of moderate 
energy restriction. The model of energy availability was chosen to set the energy deficit in these 
subjects with a level of 30 kcal∙kg-1 FFM∙day-1 corresponding to a threshold below which there is 
significant disruption to metabolic and hormonal systems within the body (Loucks et al. 2011). The 
notional energy deficit of ~15 kcal∙kg-1 FFM∙day-1 in these subjects was equivalent to a range of 
absolute energy availability of 1690-2200 kcal • day-1 in the male and 1210-1640 kcal • day-1 in the 
female subjects. Therefore, this cannot be completely discounted as a potential physiological factor 
that may have generated some variation in results. Nevertheless, the comparable data regardless of 
gender indicates homogeneity of the physiological responses in the current study. Therefore, this 
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should not be discarded as a potential variable affecting the current results. Nevertheless, the 
consistency of our measures (i.e. lack of outliers and low variability) suggests that this factor has not 
been a major one attempting against the homogeneity of the treatments. To our surprise, the extensive 
resistance training history of these subjects coupled with the high relative dietary protein intake (1.4 
g∙kg-1 BM∙day-1) during this short term ED was still unable to “protect” the muscle and preserve 
resting rates of MPS as measured during EB.  Given that protein synthesis is an energetically 
expensive process, it is proposed that the decrease in muscle protein synthesis observed in the present 
and previous studies (Pasiakos et al. 2010) may represent an accommodative physiological response 
to the reduced EA that subsequently down regulates non-essential metabolic pathways.  
Consistent with observations when individuals are in EB (Moore et al. 2009b; Phillips et al. 
1997), the anabolic stimulus generated by REX during energy restriction in the fasted state elevated 
rates of MPS above resting levels in the early post-exercise period. However, despite this elevation, 
exercise merely “rescued” the rate of MPS to a level that was similar to, but did not exceed, rates 
measured at rest when in EB. Accordingly, it appears the metabolic status of the muscle during short-
term (5 days) ED plus a ~10 h fast may dictate that contractile overload in isolation is not enough to 
increase FSR to values that otherwise would be reached in EB.  
The anabolic effect of protein ingestion on cell signalling and rates of protein synthesis is 
well-accepted (Breen and Phillips 2012). A recent study on young  healthy subjects involving 21 days 
of moderate ED (750 kcal∙day-1) found that high (1.6 and 2.4 g∙kg-1 BM∙day-1) protein intake rescued 
the FFM loss seen with protein intake at RDA levels (0.8 g∙kg-1 BM) (Pasiakos et al. 2013). This 
study is the first to determine the acute muscle anabolic response to different quantities of protein 
ingested after exercise undertaken during short-term ED. These results highlight the importance of 
combining REX with increased protein availability to maximize protein accretion in a chronic 
intervention. Furthermore it is reported that a dose-dependent response of myofibrillar protein 
synthesis to protein ingestion in individuals in short-term ED: a hierarchical increase above resting 
energy balance for rates of muscle protein synthesis with ingestion of 15 and 30 g whey protein was 
observed (Figure 4.4). This effect is evident when protein ingestion is considered in both absolute and 
relative terms to body mass and fat free mass (Figure 4.5). Of note a ceiling or threshold for the dose 
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response between protein intake and myofibrillar protein synthesis under the conditions of the current 
study was not observed.  These results suggests that the optimal amount of protein to maximise the 
response to a single bout of resistance training while in ED may be above the level (20 g) that is 
typically prescribed for individuals who are in EB (Moore et al. 2009a). Regardless, the provision of 
exogenous amino acid during ED appears to be a pre-requisite for supporting muscle protein synthesis 
and allowing a net increase in muscle protein above that achieved at rest while in energy balance  
(Biolo et al. 1995b; Phillips et al. 1997).  
In the present study, no sex-based differences for any of the cellular markers of ‘muscle 
anabolism’ measured was found, providing further support for the notion that both acute and chronic 
responses to resistance exercise and/or protein ingestion are similar between younger men and women 
(Phillips et al. 2013; Smith et al. 2012; Smith and Mittendorfer 2012; West et al. 2012). The muscle 
anabolic responses in ED persisted despite a wide range of differences in body mass and body 
composition (Table 4.1). This also suggests that the dysregulation of luteinizing hormone pulsatility 
and bone metabolism hormones by reduced energy availability in females, which affect menstrual 
cycle and bone quality respectively (Ihle and Loucks 2004; Loucks and Thuma 2003), do not precede 
differential MPS in females compared to males.  However, there was a moderate relationship between 
the relative quantity of protein ingested and the muscle fractional synthetic rate such that it is not 
possible to rule out that the (smaller) females may have benefited, at least in part, from a greater 
relative protein dose (Figure 4.5). Whether a greater relative effect on MPS in females would 
ameliorate any potential sex-based difference in ED seems unlikely. Indeed Phillips and co-workers 
(2013) have recently reported that the capacity of skeletal muscle to hypertrophy during 20 wk 
resistance training program is to a large extent, genetically determined, rather than being sex-
dependent. Regardless, the data indicate that the physiological response in skeletal muscle following 
the short-term ED protocol employed in the current study was similar in male and female subjects and 
they appear equally responsive to an acute bout of REX and post exercise protein intake in ED. 
In agreement with recent observations by others (Pasiakos et al. 2013), the mTOR associated 
translational signaling responses did not reveal any differences at rest between EB and ED. Indeed, 
resistance exercise performed under conditions of ED and overnight fast had little effect in promoting 
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the phosphorylation of any of the proteins of interest. This finding is in contrast to our group previous 
study (Camera et al. 2010) and the results from several other groups (Creer et al. 2005; Dreyer et al. 
2006) when resistance exercise was undertaken in the fasted state in EB. However, a marked increase 
in translational signaling following the post exercise ingestion of protein was observed, with subtle 
differences between the response to 15 g and 30 g of whey protein. Moreover, we have previously 
reported a hierarchical signaling response to increasing quantities of whey protein ingestion i.e. more 
protein ingested resulted in greater phosphorylation of p70 S6K (Areta et al. 2013). The results of the 
current study indicate that ED may alter the magnitude of signal for translation initiation in response 
to acute exercise and protein intake (Figure 4.7). Importantly, the similar phosphorylation responses 
were not mirrored by myofibrillar FSR and support previous work showing translation initiation 
signaling can be indicative of elevated MPS compared to baseline (Burd et al. 2010a; Fry et al. 2011; 
Kumar et al. 2009a), but does not accurately reflect the magnitude or duration of the MPS response 
(Areta et al. 2013).  
The ubiquitin ligases MuRF-1, and Atrogin are key regulatory steps of the ubiquitin-
proteasomal protein degradation. Originally linked to muscle atrophy (Bodine et al. 2001) they seem 
to be important in the myofibril remodelling process after a bout of REX (Yang et al. 2006). Energy 
deficit did not generate any differences in muscle transcriptional activity of any gene of interest at rest 
compared with resting EB (Figure 4.8). Protein intake in sufficient quantities has been previously 
shown to blunt the exercise induced increase in MuRF-1 mRNA abundance (Areta et al. 2013; 
Borgenvik et al. 2012; Louis et al. 2007). Interestingly, increases in Atrogin mRNA abundance 
following high intensity exercise is not consistently observed in vivo humans (Areta et al. 2013; Louis 
et al. 2007; Raue et al. 2007) and our results showing elevated Atrogin mRNA following resistance 
exercise in all treatments suggests that ED may promote the catabolic activity of this specific 
atrogene. Importantly, protein ingestion did not alter the elevated transcriptional activity of Atrogin 
during recovery from resistance exercise in energy deficit but direct measures of protein breakdown 
are required to determine the physiological relevance of the increase in Atrogin mRNA expression 
when exercising in ED. 
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The results from previous studies have shown resistance exercise and protein feeding 
augments amino acid transporter mRNA and protein abundance in skeletal muscle (Areta et al. 2013; 
Drummond et al. 2011; Drummond et al. 2010). Here the first information on the effect of energy 
deficit on these transport proteins is provided. Either little effect or a down regulation of SNAT2 and 
LAT1 mRNA are reported, respectively, in individuals who are in ED, suggestive of a suppression of 
global amino acid transporter expression. The physiological significance of changes in amino acid 
transporter mRNA expression are speculative, although the down regulation of transporter expression 
could potentially result in a depression of the capacity for amino acid uptake into skeletal muscle 
when in chronic ED. This phenomenon may be consequence of a physiological adjustment to lower 
EA. Given that protein turnover is an energy-costly process, shifting the system towards a state of 
reduced protein turnover would increase EA for processes of higher priority for survival.  With the 
likelihood that amino acid transporters are rate limiting for muscle protein synthesis, research on the 
physiological significance of changes in amino acid transporter mRNA and, ultimately, protein 
expression with exercise and dietary manipulations is warranted. 
In conclusion, these results provide novel data on the effect of a short-term energy restricted 
diet on skeletal muscle metabolism in vivo humans. The data show that 5 days of moderate ED,   (EA 
equivalent to 30 kcal∙kg-1 FFM∙day-1) was sufficient to inhibit rates of MPS. Despite lacking 
information on muscle protein breakdown and net protein balance, previous studies indicate that acute 
quantification of MPS  are predictive of chronic adaptation to exercise and nutrition stimuli (Hartman 
et al. 2007; Wilkinson et al. 2007). Therefore, it was hypothesized that if such an energy deficit was 
sustained for prolonged (i.e., several months) periods, it would lead to significant reductions in 
muscle mass. Also, it was found that targeted use of a bolus of high quality protein ingestion (15-30 
g) has the capacity to off-set the muscle catabolic state. Moreover, the data suggests that the dose 
required to maximally stimulate muscle protein synthesis under conditions of mild energy deficit is 
likely to be higher than for individuals in energy balance. Regardless, the current investigation 
provide important new information on the effect of ED on skeletal muscle metabolism and revealing 
that the lower rates of muscle protein synthesis at rest in ED can be rescued/augmented by the 
combined anabolic effects of REX and protein ingestion.  
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The overall aim of the studies undertaken for this thesis was to investigate the skeletal muscle 
responses to different delivery patterns of protein and amino acids in order to optimize rates of muscle 
protein synthesis. A secondary aim was to utilise the results of these investigations to inform 
nutritional practices for humans wishing to maintain or maximise their skeletal muscle mass. Several 
experimental techniques were used to fulfil these aims. For the first experiment (Chapter two), a cell 
model incorporating measurements of intracellular signalling pathways status, cell diameter and 
radioactive isotope incorporation into protein was utilized. For the next two experiments (Chapters 
three and four) human models comprising the use of skeletal muscle biopsies to assess intracellular 
signalling pathways status, gene expression and stable isotope labelled amino acid incorporation into 
myofibrillar proteins were employed. In the three independent but related studies, these primary 
outcomes informed how different protein and amino acid delivery variables, with and without the use 
of contractile stimulus, can modulate muscle anabolic response. 
The first study (chapter two) characterized the leucine dose-response of the mTOR signalling 
pathway, protein synthesis and cell diameter in C2C12 cells. The leucine content of a protein is a 
main factor driving muscle protein synthesis in mammals. Therefore it was hypothesized that there 
exists a leucine “threshold concentration” at which the protein synthetic machinery is activated, and a 
saturation concentration beyond which there is no further anabolic response. The findings support this 
hypothesis. Cell diameter was unaltered by chronic exposure to ≤1.51mM leucine concentrations but 
was increased and the response saturated with ≥5 mM concentrations. Furthermore, for selected 
proteins of the mTOR signalling pathway, p70S6K phosphorylation at Thr389 was further increased 
in ≥5 mM treatments compared to 1.51 mM. Taken collectively, these results indicate that there exists 
an anabolic leucine threshold between 1.51 and 5 mM under the conditions of the present experiment. 
The results of this study are important because they are the first to systematically evaluate the 
effects of different leucine concentrations on a combination of markers of anabolism. Consequently, 
they set the foundation for further experiments into factors with the potential to up or down-regulate 
the anabolic response triggered by leucine. It is expected that (potential) up-regulatory (e.g. 
contraction, increased growth factor and energy substrate availability) and down-regulatory (e.g. 
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energy deprivation, endoplasmic reticulum stress, and increased fatty acid availability) factors would 
decrease/increase the concentration at which leucine triggers cellular responses. However, it is 
important to note that that the range of leucine concentration examined were supra-physiological and 
how these relate to in vivo human models cannot be determined from mice immortalized myoblasts in 
vitro. Nevertheless, it is expected that factors up-regulating cell anabolic response to leucine would be 
subsequently tested in proof of principle experiments in humans to assess their viability for 
optimizing human skeletal muscle growth. 
The second study (chapter three), investigated the effects of different protein ingestion 
protocols on cell signalling and rates of myofibrillar protein synthesis during prolonged (12 h) 
recovery after a bout of resistance exercise. Specifically, the modulatory effect of three different 
isonitrogenous protein ingestion patterns throughout a day, each of which mimicked different daily 
meal patterns, was determined. It was hypothesized that following resistance exercise, repeated 
feedings of 20 g of protein every 3 hours would be superior for up-regulating the protein synthetic 
machinery (i.e., cell signalling) and maximally stimulating myofibrillar protein synthesis compared to 
two other isonitrogenous treatments of sub-optimal daily distribution of protein ingestion. The results 
of this study confirm this hypothesis, making this the first study in the literature to show that protein 
timing and distribution can be an independent factor capable of modulating skeletal muscle protein 
synthesis. 
The results from this study are novel because they close the existing gap in the literature 
between daily protein and optimal post-exercise protein dose recommendations. For that reason, these 
are likely to directly impact the current nutritional practices for young physically active population 
aiming to increase muscle mass gains. Consequently, the relevance of the timing and distribution of 
nutrients as independent from total daily protein is highlighted by its significant capacity to modulate 
the skeletal muscle adaptive response. 
One interesting finding of study two was that the response of mTOR signalling and ubiquitin 
proteasome pathways indicated that ingestion of 40 g of protein, compared 20 g, generated a higher 
anabolic milieu by down-regulating the atrophy related gene MuRF-1 and up-regulating of the 
intracellular signalling response. Therefore should it should not be overlooked that bigger protein 
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boluses could possibly exert a more anabolic stimulus that would become evident in muscle mass 
gains when repeated over time. 
Another interesting phenomenon observed in this study was the lack of differences in the 
myofibrillar protein synthesis response between treatments in the first four hours of the 12 h recovery. 
This indicates that 1) timing and distribution of protein becomes more important later (>4h) in 
recovery after the exercise stimulus, 2) skeletal muscle becomes less responsive to amino acid 
availability >4h after a resistance exercise bout, and 3) the time dependent loss of sensitivity can be 
overridden by optimal timing and distribution of protein ingestion. 
In conclusion, considering the capacity of timing and distribution of protein ingestion to 
modulate skeletal muscle protein synthesis, it is surprising that this topic has been only marginally 
investigated in the past. If the same response observed here is evident in the general population using 
whole foods, the current recommended dietary intake (RDI) values for protein should be reassessed 
via incorporating daily protein distribution as a factor modulating protein balance. Moreover a new 
value or index for qualifying the distribution of protein throughout the day should be developed. 
However, extensive research will be required to substantiate these speculations. Therefore, key 
questions that will need to be addressed are: how do other populations (e.g. elderly, obese, physically 
inactive) respond to different protein distribution patterns? Would the same response be evident 
without a resistance exercise bout? How would the use of whole foods, or slow proteins with and 
without the co-ingestion of different quantities of macronutrients influence the results? Would timing 
and distribution of protein ingestion become a less critical factor when higher amounts of protein 
ingestion are provided throughout a day? All of these questions and the possible permutations 
between them are fertile ground for future studies. 
The final study, presented in chapter four, determined the muscle anabolic response to 
resistance exercise and protein ingestion when undertaken in a state of energy deficit. Dietary energy 
deficit induced loss of fat free mass can be reversed by concomitant resistance exercise training and 
increased daily protein intake. Consequently, it was hypothesized that even a mild energy deficit 
would down-regulate myofibrillar protein synthesis and associated signalling pathways, and that 
resistance exercise and protein ingestion would acutely up-regulate the anabolic response, with no 
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gender based differences. The findings reported here confirm this hypothesis. This is the first study to 
show that a bout of resistance exercise rescues the down-regulation of myofibrillar protein synthesis 
induced by energy deficit and that increasing doses of ingested protein after exercise further increase 
these values above those of observed in resting energy balance. 
The results arising from the third study are important because they are expected to lead to 
improved weight loss practices without concomitant loss of muscle mass. These are directly relevant 
to healthy and physically active and athletic population aiming to improve their body composition. 
Nevertheless, the current findings may also have major importance for optimizing nutritional and life-
style related interventions for the overweight and obese. Considering the magnitude of the current 
global obesity epidemic and the increasing necessity of treatments to reduce fat mass while avoiding 
the loss of muscle mass these results are therefore relevant from a health perspective. However, only 
with future research will unveil the response of these specific populations. 
The wide range of body and fat free masses of the experimental subjects allowed to analyse 
the effect of protein intake relative to body mass and fat free mass and linear relationships between 
these and myofibrillar protein synthesis was found. Indicating that the higher provision of protein 
relative to body mass and fat free mass in lighter individuals showed beneficial compared to heavier 
individuals. Therefore, the results from this study suggest (but do not prove) that at least in the heavier 
and average weight individuals a protein intake higher than the maximum provided may have further 
increased myofibrillar protein synthesis. This indicates that the 20 g of protein suggested as maximal 
stimulatory under energy balance, may be elevated under energy deficit. 
The results of this study raise important questions for future research. Some of the key 
questions that will further shed light on this topic are: Is there a threshold of energy availability for 
down-regulating muscle protein synthesis? Is there an inverse relationship between energy availability 
and the amount of protein required to increase muscle protein synthesis by a given magnitude? Is 
resting muscle protein synthesis diminished after long periods of reduced energy availability? Is the 
duration of the muscle protein synthesis response to exercise and protein ingestion altered with 
reduced energy availability? Would the co-ingestion of protein with an energy substrate such as 
carbohydrates enhance the muscle protein synthetic response during reduced energy availability? The 
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answer to these questions will further optimize practices aimed at reducing fat mass without 
concomitant muscle mass loss. 
In conclusion, the results from the studies undertaken in this thesis provide novel findings and 
improve the current understanding of muscle protein synthesis regulation by exercise and protein 
ingestion. Both timing and distribution of protein intake and the muscle protein synthesis response 
during periods of low energy availability are areas of research that have not been extensively 
investigated and the current findings provide new perspective for future research. Further studies may 
consider assessing the effects of the timing/distribution of protein ingestion and energy availability 
regulation of other related cellular mechanisms (e.g. micro RNAs, DNA methylation, STARS 
signalling pathway) and protein breakdown in skeletal muscle. Additionally, future studies addressing 
the validity of acute measurements in predicting chronic adaptation and changes in muscle phenotype 
will become essential. In the meantime, the results presented in this thesis show that daily timing and 
distribution of protein can have significant impact on the regulation of muscle protein synthesis after 
resistance exercise and that the down-regulation of muscle protein synthesis by reduced energy 
availability can be rescued by resistance exercise and protein ingestion in a young, healthy and 
resistance exercise trained population. All of the findings represent novel information in the area of 
muscle protein regulation, and are expected to positively impact and improve contemporary and 
future nutritional and life-style related practices. 
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